Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Open accessAbstract
Researchers have discovered associations between elements of the intestinal microbiome (including specific microbes, signaling pathways, and microbiota-related metabolites) and risk of colorectal cancer (CRC). However, it is unclear whether changes in the intestinal microbiome contribute to the development of sporadic CRC or result from it. Changes in the intestinal microbiome can mediate or modify the effects of environmental factors on risk of CRC. Factors that affect risk of CRC also affect the intestinal microbiome, including overweight and obesity; physical activity; and dietary intake of fiber, whole grains, and red and processed meat. These factors alter microbiome structure and function, along with the metabolic and immune pathways that mediate CRC development. We review epidemiologic and laboratory evidence for the influence of the microbiome, diet, and environmental factors on CRC incidence and outcomes. Based on these data, features of the intestinal microbiome might be used for CRC screening and modified for chemoprevention and treatment. Integrated prospective studies are urgently needed to investigate these strategies.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 290 cited sources checked · 0 supported · 0 flagged
- Premisecitation
About 50%-60% of incident colorectal cancer cases in the United States are estimated to be attributable to modifiable risk factors.
“Approximately 50%–60% of incident cases of CRC in the US are estimated to be attributable to modifiable risk factors4, 5”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Islami, 2018, Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, CA Cancer J Clin
Not checked in the free run.
- cites [5] Mima, 2016, Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location, Clin Transl Gastroenterol source
Not checked in the free run.
- Interpretationreasoning
Changes in the intestinal microbiome can mediate or modify how environmental factors affect colorectal cancer risk.
“Changes in the intestinal microbiome can mediate or modify the effects of environmental factors on risk of CRC.”
Quote in the paperSubstantial claim - Premisecitation
Specific microbiome and metabolome changes occur across stages of colorectal neoplasia, from adenomatous polyps to early cancer to metastatic disease.
“Specific changes in the microbiome and metabolome occur during different stages of colorectal neoplasia, from adenomatous polyps to early-stage cancer to metastatic disease, supporting an etiological and diagnostic role for the microbiome.18–20”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [18] Feng, 2015, Gut microbiome development along the colorectal adenoma-carcinoma sequence, Nat Commun source
Not checked in the free run.
- cites [19] Nakatsu, 2015, Gut mucosal microbiome across stages of colorectal carcinogenesis, Nat Commun source
Not checked in the free run.
- cites [20] Yachida, 2019, Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer, Nat Med source
Not checked in the free run.
- Premisecitation
Fusobacterium nucleatum levels in tumor tissue are associated with lower T cell infiltration.
“Moreover, levels of F nucleatum in tumor tissue have been associated with lower infiltration by T cells,29, 30”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [29] Nosho, 2016, Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer, World J Gastroenterol source
Not checked in the free run.
- cites [30] Mima, 2015, Fusobacterium nucleatum and T cells in colorectal carcinoma, JAMA Oncol source
Not checked in the free run.
- Premisecitation
Associations have been found between components of the intestinal microbiome and colorectal cancer risk.
“Researchers have discovered associations between elements of the intestinal microbiome (including specific microbes, signaling pathways, and microbiota-related metabolites) and risk of colorectal cancer (CRC).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Song, 2019, Environmental factors, gut microbiota, and colorectal cancer prevention, Clin Gastroenterol Hepatol source
Not checked in the free run.
- cites [7] Scott, 2019, International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis, Gut source
Not checked in the free run.
- Premisecitation
Among colorectal cancer patients with distant metastases, nearly identical viable Fusobacterium strains were found at similar relative abundances in paired primary tumors and metastases.
“More recently, among CRC patients with distant metastases, nearly identical, viable strains of Fusobacterium were found at similar relative abundances in paired primary tumors and metastases.”
Quote in the paperSubstantial claim - Interpretationcitation
Fusobacterium appears to be an important component of the tumor microenvironment.
“So, Fusobacterium appears to be an important component of the tumor microenvironment.34”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] Bullman, 2017, Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer, Science source
Not checked in the free run.
- Premisecitation
The intestinal microbiome can influence the efficacy or toxicity of therapeutic agents, including immunotherapies.
“The intestinal microbiome can also influence the efficacy or toxicity of therapeutic agents, including immunotherapies.8”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Roy, 2017, Microbiota: a key orchestrator of cancer therapy, Nat Rev Cancer source
Not checked in the free run.
- Premisenone given
Factors that affect colorectal cancer risk also affect the intestinal microbiome, including overweight and obesity, physical activity, and intake of fiber, whole grains, and red and processed meat.
“Factors that affect risk of CRC also affect the intestinal microbiome, including overweight and obesity; physical activity; and dietary intake of fiber, whole grains, and red and processed meat.”
Quote in the paperSubstantial claim - Interpretationreasoning
Fusobacterium nucleatum might contribute to the serrated pathway of colorectal cancer development.
“Given that these features characterize serrated neoplasia,31 F nucleatum might contribute to the serrated pathway of CRC development.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Rashtak, 2017, Sessile serrated polyps and colon cancer prevention, Cancer Prev Res (Phila) source
Not checked in the free run.
- Interpretationreasoning
The intestinal microbiome might be modified as part of colorectal cancer prevention strategies.
“The intestinal microbiome might therefore be modified as part of CRC preventative strategies.”
Quote in the paperSubstantial claim - Premisecitation
Fecal microbiome studies using 16S rRNA or shotgun metagenomic sequencing found Fusobacterium nucleatum increased in fecal samples from colorectal cancer or adenoma patients compared with controls.
“studies of fecal microbiomes that used either 16s rRNA or shotgun metagenomic sequencing found that F nucleatum to be increased in fecal samples from patients with CRC or adenoma compared with controls (Table 1).15, 18, 35–39”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [15] Ahn, 2013, Human gut microbiome and risk for colorectal cancer, J Natl Cancer Inst source
Not checked in the free run.
- cites [18] Feng, 2015, Gut microbiome development along the colorectal adenoma-carcinoma sequence, Nat Commun source
Not checked in the free run.
- cites [35] Zackular, 2014, The human gut microbiome as a screening tool for colorectal cancer, Cancer Prev Res (Phila) source
Not checked in the free run.
- cites [36] Zeller, 2014, Potential of fecal microbiota for early-stage detection of colorectal cancer, Mol Syst Biol source
Not checked in the free run.
- cites [37] Vogtmann, 2016, Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing, PLoS One source
Not checked in the free run.
- cites [38] Momen-Heravi, 2017, Periodontal disease, tooth loss and colorectal cancer risk: results from the Nurses’ Health Study, Int J Cancer source
Not checked in the free run.
- cites [39] Liang, 2017, Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer, Clin Cancer Res source
Not checked in the free run.
- Interpretationreasoning
These risk factors change microbiome structure and function and the metabolic and immune pathways that mediate colorectal cancer development.
“These factors alter microbiome structure and function, along with the metabolic and immune pathways that mediate CRC development.”
Quote in the paperSubstantial claim - Premisecitation
Migration and prospective cohort studies have established that diet and lifestyle importantly affect colorectal cancer development.
“Over the past few decades, migration studies and prospective cohort studies have established the important effects of diet and lifestyle in the development of CRC.3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Song, 2015, Nutrients, foods, and colorectal cancer prevention, Gastroenterology source
Not checked in the free run.
- Interpretationreasoning
Fusobacterium nucleatum reduces the anti-tumor immune response.
“supporting studies reporting that F nucleatum reduces the anti-tumor immune response.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [29] Nosho, 2016, Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer, World J Gastroenterol source
Not checked in the free run.
- cites [30] Mima, 2015, Fusobacterium nucleatum and T cells in colorectal carcinoma, JAMA Oncol source
Not checked in the free run.
- Premisecitation
Increasing data indicate that changes in the intestinal microbiome allow environmental risk factors to initiate and promote colorectal cancer.
“Increasing data indicate that changes in the intestinal microbiome allow environmental risk factors to initiate and promote CRC.6, 7”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Song, 2019, Environmental factors, gut microbiota, and colorectal cancer prevention, Clin Gastroenterol Hepatol source
Not checked in the free run.
- cites [7] Scott, 2019, International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis, Gut source
Not checked in the free run.
- Premisecitation
Fusobacterium DNA and RNA sequences are increased in tumor compared with non-tumor specimens.
“Two independent studies reported increased levels of Fusobacterium DNA and RNA sequences in tumor compared with non-tumor specimens.21, 22”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [21] Castellarin, 2012, Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma, Genome Res source
Not checked in the free run.
- cites [22] Kostic, 2012, Genomic analysis identifies association of Fusobacterium with colorectal carcinoma, Genome Res source
Not checked in the free run.
- Premisecitation
Fusobacterium nucleatum is associated with consensus molecular subtype 1 of colorectal cancer.
“A study associated F nucleatum with the consensus molecular subtype 1 of CRC,32”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Purcell, 2017, Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer, Sci Rep source
Not checked in the free run.
- Premisecitation
Numerous studies of multiple cohorts worldwide have found similar associations between Fusobacterium nucleatum and colorectal cancer.
“Numerous studies, of multiple cohorts, of patients with CRC worldwide have found similar associations.23–27”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [23] Flanagan, 2014, Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome, Eur J Clin Microbiol Infect Dis source
Not checked in the free run.
- cites [24] Ito, 2015, Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway, Int J Cancer source
Not checked in the free run.
- cites [25] Li, 2016, Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients, World J Gastroenterol source
Not checked in the free run.
- cites [26] Mima, 2016, Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis, Gut source
Not checked in the free run.
- cites [27] Tahara, 2014, Fusobacterium in colonic flora and molecular features of colorectal carcinoma, Cancer Res source
Not checked in the free run.
- Premisecitation
Patients with colorectal cancer have a less diverse microbiome than healthy individuals.
“Patients with CRC have a less diverse microbiome than healthy individuals.15”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Ahn, 2013, Human gut microbiome and risk for colorectal cancer, J Natl Cancer Inst source
Not checked in the free run.
- Interpretationreasoning
These oral bacteria are associated with distinct mucosal gene expression profiles that might contribute to colorectal cancer development.
“These bacteria have been associated with distinct mucosal gene expression profiles, which might contribute to development of CRC.”
Quote in the paperSubstantial claim - Premisecitation
A meta-analysis of four case-control metagenome studies found Bacteroides fragilis was the only species consistently enriched in intestinal microbiomes of colorectal cancer patients worldwide.
“A meta-analysis of 4 case–control studies of metagenomes of patients with CRC found that Bacteroides fragilis was the only species that was consistently enriched in intestinal microbiomes of patients with CRC worldwide.46”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Dai, 2018, Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers, Microbiome source
Not checked in the free run.
- Premisecitation
Antibody titers to Salmonella ser. Typhimurium were higher in colorectal cancer cases than controls in the United States and the Netherlands.
“Antibody titers to Salmonella ser. Typhimurium were higher in CRC cases than controls in the US and the Netherlands.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Kato, 2013, Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk, Nutr Cancer source
Not checked in the free run.
- Premisecitation
An independent population-based linkage study in the Netherlands found increased colorectal cancer incidence among residents with reported enteric salmonellosis compared with the general population.
“The investigators analyzed cancer registry and public health surveillance data and found an increased incidence of CRC, compared with the general population, among residents who with reported enteric (not systemic) salmonellosis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Mughini-Gras, 2018, Increased colon cancer risk after severe Salmonella infection, PLoS One source
Not checked in the free run.
- Premisecitation
The enteric virome and mycobiome have been linked with colorectal cancer.
“The enteric virome and mycobiome (fungal microbiome) have also been linked with CRC.72–74”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [72] Nakatsu, 2018, Alterations in enteric virome are associated with colorectal cancer and survival outcomes, Gastroenterology source
Not checked in the free run.
- cites [73] Coker, 2019, Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer, Gut source
Not checked in the free run.
- cites [74] Hannigan, 2018, Diagnostic potential and interactive dynamics of the colorectal cancer virome, MBio source
Not checked in the free run.
- Premisecitation
Oral microbiome profiling identified several oral biofilm members with different abundances in colorectal cancer patients compared with controls, including Haemophilus, Parvimonas, Prevotella, Alloprevotella, Lachnoanaerobaculum, Neisseria, and Streptococcus.
“oral microbiome profiling studies identified several members of the oral biofilms with different abundances in patients with CRC compared with controls, including Haemophilus, Parvimonas, Prevotella, Alloprevotella, Lachnoanaerobaculum, Neisseria, and Streptococcus.54, 55”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [54] Yang, 2019, Prospective study of oral microbiome and colorectal cancer risk in low-income and African American populations, Int J Cancer source
Not checked in the free run.
- cites [55] Flemer, 2018, The oral microbiota in colorectal cancer is distinctive and predictive, Gut source
Not checked in the free run.
- Premisecitation
Besides Fusobacterium, other oral bacteria and periodontal disease markers are enriched in colorectal tumors and feces, including Porphyromonas, Peptostreptococcus, and Parvimonas micra.
“Besides Fusobacterium, other oral bacteria and markers of periodontal disease are enriched in colorectal tumors and feces of patients, including the genera of Porphyromonas and Peptostreptococcus, and Parvimonas micra.15, 35, 37, 38, 53”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [15] Ahn, 2013, Human gut microbiome and risk for colorectal cancer, J Natl Cancer Inst source
Not checked in the free run.
- cites [35] Zackular, 2014, The human gut microbiome as a screening tool for colorectal cancer, Cancer Prev Res (Phila) source
Not checked in the free run.
- cites [37] Vogtmann, 2016, Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing, PLoS One source
Not checked in the free run.
- cites [38] Momen-Heravi, 2017, Periodontal disease, tooth loss and colorectal cancer risk: results from the Nurses’ Health Study, Int J Cancer source
Not checked in the free run.
- cites [53] Shah, 2018, Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer, Gut source
Not checked in the free run.
- Premisecitation
Only one fecal microbiome study found Escherichia coli enriched in samples of colorectal cancer patients.
“However, only 1 fecal microbiome study found E coli to be enriched in samples of CRC patients.18”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Feng, 2015, Gut microbiome development along the colorectal adenoma-carcinoma sequence, Nat Commun source
Not checked in the free run.
- Interpretationcitation
Strategies to detect specific bacteria or bacterial DNA sequences might be used in screening for early-stage colorectal adenomas or carcinomas.
“Strategies to detect specific bacteria or bacterial DNA sequences might be used in screening for early-stage colorectal adenomas or carcinomas.60, 61”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [60] Sun, 2016, Gut microbiota, inflammation and colorectal cancer, Genes Dis source
Not checked in the free run.
- cites [61] Abdulamir, 2011, The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role, J Exp Clin Cancer Res source
Not checked in the free run.
- Interpretationreasoning
These findings support the reported association between periodontal disease and colorectal cancer risk.
“These findings support the reported association of periodontal disease with CRC risk.38, 56, 57”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [38] Momen-Heravi, 2017, Periodontal disease, tooth loss and colorectal cancer risk: results from the Nurses’ Health Study, Int J Cancer source
Not checked in the free run.
- cites [56] Hu, 2018, Risk of colorectal cancer in patients with periodontal disease severity: a nationwide, population-based cohort study, Int J Colorectal Dis source
Not checked in the free run.
- cites [57] Michaud, 2018, Periodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study, J Natl Cancer Inst source
Not checked in the free run.
- Premisecitation
Enterotoxigenic Bacteroides fragilis is associated with colorectal cancer.
“Enterotoxigenic Bacteroides fragilis (ETBF), which produces the Bacteroides fragilis toxin, has been associated with CRC.”
Quote in the paperSubstantial claim - Premisecitation
Epidemiology studies associated a serologic response to Helicobacter pylori with increased colorectal cancer risk among African Americans.
“Moreover, epidemiology studies associated a serologic response to Helicobacter pylori with increased risk of CRC among African Americans.71”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Butt, 2019, Serologic response to Helicobacter pylori proteins associated with risk of colorectal cancer among diverse populations in the United States, Gastroenterology source
Not checked in the free run.
- Premisecitation
Enterotoxigenic Bacteroides fragilis is enriched in fecal samples of colorectal cancer patients compared with controls.
“However, ETBF was reported to be enriched in fecal samples of patients with CRC compared with controls.35, 44, 45”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [35] Zackular, 2014, The human gut microbiome as a screening tool for colorectal cancer, Cancer Prev Res (Phila) source
Not checked in the free run.
- cites [44] Toprak, 2006, A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer, Clin Microbiol Infect source
Not checked in the free run.
- cites [45] Wang, 2012, Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers, ISME J source
Not checked in the free run.
- Premisecitation
Streptococcus bovis or gallolyticus has been associated with colorectal cancer.
“Streptococus bovis or gallolyticus has been associated with CRC (see ref 61).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Abdulamir, 2011, The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role, J Exp Clin Cancer Res source
Not checked in the free run.
- Premisecitation
Two studies found significant enrichment of enterotoxigenic Bacteroides fragilis in tumor tissues compared with controls or adjacent normal tissues.
“Among them, 2 found significant enrichment of ETBF in tumor tissues compared to tissues from controls or adjacent normal tissues40, 43.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40] Boleij, 2015, The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients, Clin Infect Dis source
Not checked in the free run.
- cites [43] Viljoen, 2015, Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer, PLoS One source
Not checked in the free run.
- Premisecitation
Similar networks of oral bacteria were found in oral and colonic mucosal samples from individuals with colonic neoplasia and controls.
“Interestingly, similar networks of oral bacteria were found samples from oral and colonic mucosal surfaces of individuals with colonic neoplasia and controls.55”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Flemer, 2018, The oral microbiota in colorectal cancer is distinctive and predictive, Gut source
Not checked in the free run.
- Premisecitation
Levels of mucosa-associated and internalized Escherichia coli associate with the cell proliferation index assessed by Ki-67 expression.
“Levels of mucosa-associated and internalized E coli associate with the cell’s proliferation index, assessed by Ki-67 expression.51”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Bonnet, 2014, Colonization of the human gut by E. coli and colorectal cancer risk, Clin Cancer Res source
Not checked in the free run.
- Interpretationcitation
Infection-associated colorectal cancer might develop through transformation of cells to premalignant lesions, adenomas, and malignancies.
“Infection-associated CRC might develop via transformation of cells to premalignant lesions, adenomas, to malignancies.”
Quote in the paperSubstantial claim - Premisecitation
Higher proportions of patients with familial adenomatous polyposis or sporadic premalignant lesions had intestinal mucosa positive for enterotoxigenic Bacteroides fragilis than controls.
“Higher proportions of patients with familial adenomatous polyposis42 or sporadic premalignant lesions had intestinal mucosa that tested positive for ETBF than of controls.41”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41] Purcell, 2017, Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia, PLoS One source
Not checked in the free run.
- cites [42] Dejea, 2018, Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria, Science source
Not checked in the free run.
- Premisecitation
Leakage of microbial products such as lipopolysaccharide causes metabolic endotoxemia.
“Leakage of microbial products, such as the endotoxin lipopolysaccharide (LPS), causes metabolic endotoxemia.101”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [101] Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes source
Not checked in the free run.
- Premisecitation
The meta-analysis could not establish that these taxa contributed to colorectal cancer development because the included studies were cross-sectional.
“it could not establish that these taxa contributed to development of CRC, due to the cross-sectional design of the included studies”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] Greathouse, 2019, Gut microbiome meta-analysis reveals dysbiosis is independent of body mass index in predicting risk of obesity-associated CRC, BMJ Open Gastroenterol source
Not checked in the free run.
- Premisecitation
Some dietary intervention studies associated weight loss with reduced abundance of short-chain fatty acid-producing bacteria.
“Some dietary intervention studies, paradoxically, associated weight loss with reduced abundance of SCFA-producing bacteria.84, 90–93”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [84] Duncan, 2008, Human colonic microbiota associated with diet, obesity and weight loss, Int J Obes (Lond) source
Not checked in the free run.
- cites [90] Pataky, 2016, Impact of hypocaloric hyperproteic diet on gut microbiota in overweight or obese patients with nonalcoholic fatty liver disease: a pilot study, Dig Dis Sci source
Not checked in the free run.
- cites [91] Simoes, 2014, Impact of a very low-energy diet on the fecal microbiota of obese individuals, Eur J Nutr source
Not checked in the free run.
- cites [92] Cotillard, 2013, Dietary intervention impact on gut microbial gene richness, Nature source
Not checked in the free run.
- cites [93] Walker, 2011, Dominant and diet-responsive groups of bacteria within the human colonic microbiota, ISME J source
Not checked in the free run.
- Interpretationnone given
Obesity-associated changes in intestinal microbes and their metabolites may also contribute to carcinogenesis.
“Obesity-associated changes in the intestinal microbes and their metabolites may also contribute to carcinogenesis.”
Quote in the paperNot a substantial claim - Premisecitation
Bacteria that produce short-chain fatty acids are important regulators of metabolic homeostasis.
“Bacteria that produce short-chain fatty acids (SCFAs) are important regulators of metabolic homeostasis.87, 88”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [87] Sanna, 2019, Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases, Nat Genet source
Not checked in the free run.
- cites [88] Koh, 2016, From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites, Cell source
Not checked in the free run.
- Interpretationcitation
Obesity might contribute to the increasing incidence of young-onset colorectal cancer.
“Obesity might also be contributing to the increasing incidence of young-onset CRC.79”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Liu, 2019, Association of obesity with risk of early-onset colorectal cancer among women, JAMA Oncol source
Not checked in the free run.
- Premisecitation
Elite professional rugby players had a more diverse gut microbiome than controls.
“The athletes were found to have a more diverse gut microbiome than the controls.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [96] Clarke, 2014, Exercise and associated dietary extremes impact on gut microbial diversity, Gut source
Not checked in the free run.
- cites [110] Barton, 2018, The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level, Gut source
Not checked in the free run.
- Premisecitation
A large prospective study of mostly Caucasian persons associated higher lipopolysaccharide levels with increased colorectal cancer risk in men.
“A large prospective study of mostly Caucasian persons associated higher levels of LPS with increased risk of CRC in men,107”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [107] Kong, 2016, Serum endotoxins and flagellin and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, Cancer Epidemiol Biomarkers Prev source
Not checked in the free run.
- Premisecitation
Dietary intervention studies have shown that changes in body weight affect the gut microbiota.
“dietary intervention studies have shown that changes in body weight affect the gut microbiota.85”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [85] Seganfredo, 2017, Weight-loss interventions and gut microbiota changes in overweight and obese patients: a systematic review, Obes Rev source
Not checked in the free run.
- Premisecitation
Several studies of different diets associated weight loss with enrichment of Akkermansia muciniphila.
“Several studies of different diets associated weight loss with enrichment of A muciniphila.86, 93, 98, 99”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [86] Remely, 2015, Gut microbiota composition correlates with changes in body fat content due to weight loss, Benef Microbes source
Not checked in the free run.
- cites [93] Walker, 2011, Dominant and diet-responsive groups of bacteria within the human colonic microbiota, ISME J source
Not checked in the free run.
- cites [98] Candela, 2016, Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet, Br J Nutr source
Not checked in the free run.
- cites [99] Louis, 2016, Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing, PLoS One source
Not checked in the free run.
- Premisecitation
A decrease in the Firmicutes:Bacteroidetes ratio was observed in individuals who lost weight in other trials.
“A decrease in the ratio of Firmicutes:Bacteroidetes was also observed in individuals who lost weight in other trials.86”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [86] Remely, 2015, Gut microbiota composition correlates with changes in body fat content due to weight loss, Benef Microbes source
Not checked in the free run.
- Premisecitation
In patients on a non-hypocaloric low-fat intervention, weight loss was associated with an increase in short-chain fatty acid-producing bacteria including Clostridium Cluster IV, Bifidobacterium spp., and Faecalibacterium prausnitzii.
“In patients on a non-hypocaloric low-fat intervention, weight loss was associated with an increase in SCFA-producing bacteria including Clostridium Cluster IV, Bifidobacterium spp., and Faecalibacterium prausnitzii.86”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86] Remely, 2015, Gut microbiota composition correlates with changes in body fat content due to weight loss, Benef Microbes source
Not checked in the free run.
- Interpretationcitation
Akkermansia muciniphila might provide a link between obesity and colorectal cancer.
“Akkermansia muciniphila might also provide a link between obesity and CRC,96”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [96] Clarke, 2014, Exercise and associated dietary extremes impact on gut microbial diversity, Gut source
Not checked in the free run.
- Premisecitation
A prospective study in a racially diverse cohort observed that compared with the first quartile of plasma lipopolysaccharide-binding protein, the third but not fourth quartile had increased colorectal cancer risk.
“a prospective study in a racially diverse cohort observed that, compared to individuals in the first quartile of plasma LBP, those in the third, but not fourth, quartile had an increased risk of CRC.108”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] Citronberg, 2018, Plasma lipopolysaccharide-binding protein and colorectal cancer risk: a nested case-control study in the Multiethnic Cohort, Cancer Causes Control
Not checked in the free run.
- Interpretationcitation
Obesity might increase colorectal cancer risk by reducing the abundance of short-chain fatty acid-producing bacteria and short-chain fatty acid production in the intestine.
“Obesity might therefore increase risk of CRC by reducing the abundance of SCFA-producing bacteria and SCFA production in the intestine 94.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [94] Bultman, 2014, Molecular pathways: gene-environment interactions regulating dietary fiber induction of proliferation and apoptosis via butyrate for cancer prevention, Clin Cancer Res source
Not checked in the free run.
- Interpretationreasoning
Obesity might contribute to systemic inflammation by altering intestinal barrier function.
“Obesity might contribute to systemic inflammation by altering intestinal barrier function.”
Quote in the paperSubstantial claim - Premisecitation
Epidemiology studies provide evidence for an association between obesity-related metabolic and inflammatory factors, including insulin-like growth factor 1 signaling, adipokines, sex hormones, and systemic inflammation, and colorectal cancer risk.
“Epidemiology studies have provided evidence for an association between obesity-related metabolic and inflammatory factors, including changes in insulin-like growth factor 1 signaling, adipokines, sex hormones, and systemic inflammation, and CRC risk.80”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Renehan, 2015, Adiposity and cancer risk: new mechanistic insights from epidemiology, Nat Rev Cancer source
Not checked in the free run.
- Premisecitation
Obesity is associated with a significant decrease in gut microbiota diversity.
“Obesity has been associated with a significant decrease in the diversity of the gut microbiota.81, 82”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [81] Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature source
Not checked in the free run.
- cites [82] Greenblum, 2012, Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease, Proc Natl Acad Sci U S A source
Not checked in the free run.
- Premisecitation
Each 5-kg/m2 increase in body mass index is associated with a 5% increase in colorectal cancer risk.
“A meta-analysis found that each 5-kg/m2 increase in body mass index (BMI, calculated as body weight in kilograms divided by square of height in meters) is associated with 5% increase in risk of CRC.78”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] World Cancer Research Fund, American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer; 2017. Available at: https://www.wcrf.org/sites/default/files/Colorectal-Cancer-2017-Report.pdf. Accessed October 18, 2019.
Not checked in the free run.
- Premisecitation
Obese individuals who lost weight on a fat-restricted or carbohydrate-restricted low-calorie diet had increased Bacteroidetes and decreased Firmicutes, irrespective of diet type.
“Obese individuals who lost weight on a fat-restricted or carbohydrate-restricted low-calorie diet had increased abundance of Bacteroidetes and decreased Firmicutes, irrespective of diet type.83”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature source
Not checked in the free run.
- Interpretationreasoning
The observed reduction in short-chain fatty acid-producing bacteria might result from carbohydrate restriction in the diet rather than weight loss itself.
“so the observed reduction in SCFA-producing bacteria might have resulted from carbohydrate restriction in the diet, rather than the weight loss itself.”
Quote in the paperSubstantial claim - Premisecitation
Lower abundance of short-chain fatty acid-producing bacteria is associated with higher risk of type 2 diabetes.
“A lower abundance of SCFA-producing bacteria has been associated with higher risk of type 2 diabetes.89”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Zhao, 2018, Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes, Science source
Not checked in the free run.
- Premisecitation
Some but not all cross-sectional studies found enrichment of Firmicutes and depletion of Bacteroidetes in obese compared with lean individuals.
“Some83 but not all81, 84 cross-sectional studies found an enrichment of the phylum Firmicutes and depletion of the phylum Bacteroidetes in obese individuals compared with lean individuals.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [81] Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature source
Not checked in the free run.
- cites [83] Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature source
Not checked in the free run.
- cites [84] Duncan, 2008, Human colonic microbiota associated with diet, obesity and weight loss, Int J Obes (Lond) source
Not checked in the free run.
- Premisecitation
A polymorphism in the LBP gene rs2232596 was associated with higher colorectal cancer risk.
“A polymorphism in the LBP gene (rs2232596) was associated with higher risk of CRC.106”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [106] Chen, 2011, LBP and CD14 polymorphisms correlate with increased colorectal carcinoma risk in Han Chinese, World J Gastroenterol source
Not checked in the free run.
- Premisecitation
Variants in the gene encoding the vitamin D receptor affect the composition of the microbiome.
“For example, variants in the gene encoding the vitamin D receptor affect the composition of the microbiome,76”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] Wang, 2016, Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota, Nat Genet source
Not checked in the free run.
- Rests on an assumption: The composition of the microbiota is determined by genetic, environmental, and dietary factors.
- Premisecitation
Amino acids such as glutamate and deoxycholate have been associated with obesity, intestinal dysbiosis, and metabolic disorders.
“Amino acids such as glutamate and deoxycholate have also been associated with obesity, intestinal dysbiosis, and metabolic disorders.20, 95”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [20] Yachida, 2019, Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer, Nat Med source
Not checked in the free run.
- cites [95] Liu, 2017, Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention, Nat Med source
Not checked in the free run.
- Interpretationcitation
These findings indicate an interaction between the virome and bacteriome in colorectal cancer risk.
“These findings indicate an interaction between the virome and bacteriome in risk of CRC.72, 74”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [72] Nakatsu, 2018, Alterations in enteric virome are associated with colorectal cancer and survival outcomes, Gastroenterology source
Not checked in the free run.
- cites [74] Hannigan, 2018, Diagnostic potential and interactive dynamics of the colorectal cancer virome, MBio source
Not checked in the free run.
- Premisecitation
Similar findings were observed in a study comparing active versus sedentary women.
“Similar findings were observed in a study that compared active vs sedentary women.112”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] Bressa, 2017, Differences in gut microbiota profile between women with active lifestyle and sedentary women, PLoS One source
Not checked in the free run.
- Premisecitation
There was substantial heterogeneity among studies of fiber intake and colorectal cancer risk.
“However, there was substantial heterogeneity among studies.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] World Cancer Research Fund, American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer; 2017. Available at: https://www.wcrf.org/sites/default/files/Colorectal-Cancer-2017-Report.pdf. Accessed October 18, 2019.
Not checked in the free run.
- Premisecitation
Exercise was associated with reduced levels of phenylacetylglycine and trimethylamine N-oxide in urine.
“Interestingly, exercise was associated with reduced levels of phenylacetylglycine and trimethylamine N-oxide (TMAO) in urine.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [114] Cronin, 2018, A prospective metagenomic and metabolomic analysis of the impact of exercise and/or whey protein supplementation on the gut microbiome of sedentary adults, mSystems source
Not checked in the free run.
- Premisecitation
Levels of short-chain fatty acids were significantly higher in athletes compared with controls.
“For example, levels of SCFAs were significantly higher in athletes compared with controls,”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [96] Clarke, 2014, Exercise and associated dietary extremes impact on gut microbial diversity, Gut source
Not checked in the free run.
- cites [110] Barton, 2018, The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level, Gut source
Not checked in the free run.
- Premisecitation
A recent meta-analysis of 21 prospective studies found no linear association between fiber intake and colorectal cancer risk.
“According to the recent meta-analysis of 21 prospective studies, no linear association was found between fiber intake and CRC risk.78”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] World Cancer Research Fund, American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer; 2017. Available at: https://www.wcrf.org/sites/default/files/Colorectal-Cancer-2017-Report.pdf. Accessed October 18, 2019.
Not checked in the free run.
- Interpretationcitation
These findings support a role for Akkermansia muciniphila in metabolic regulation.
“These findings support the role of A muciniphila in metabolic regulation.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [96] Clarke, 2014, Exercise and associated dietary extremes impact on gut microbial diversity, Gut source
Not checked in the free run.
- cites [110] Barton, 2018, The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level, Gut source
Not checked in the free run.
- Premisecitation
A meta-analysis found a 17% reduction in colorectal cancer risk per 90 g/day increase in whole grain consumption.
“A meta-analysis found a 17% reduction in CRC risk per 90 g/day increase in consumption of whole grains.78”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] World Cancer Research Fund, American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer; 2017. Available at: https://www.wcrf.org/sites/default/files/Colorectal-Cancer-2017-Report.pdf. Accessed October 18, 2019.
Not checked in the free run.
- Premisecitation
Among species differing between athletes and controls, Akkermansia muciniphila was enriched by 16S rRNA and metagenomic sequencing and metabolic pathway analysis.
“Among the individual species that differed between athletes and controls, A muciniphila was found to be enriched by 16s rRNA and metagenomic sequencing analyses, as well as in the metabolic pathway analysis.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [96] Clarke, 2014, Exercise and associated dietary extremes impact on gut microbial diversity, Gut source
Not checked in the free run.
- cites [110] Barton, 2018, The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level, Gut source
Not checked in the free run.
- Interpretationcitation
The anti-colorectal cancer effects of fiber could be related to its effects on the gut microbiota.
“The anti-CRC effects of fiber could be related to its effects on the gut microbiota.6”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Song, 2019, Environmental factors, gut microbiota, and colorectal cancer prevention, Clin Gastroenterol Hepatol source
Not checked in the free run.
- Premisecitation
A large prospective study found that the association of dietary fiber with reduced colorectal cancer risk had a larger effect on tumors with detectable Fusobacterium nucleatum than those without.
“A large prospective study found that the association of dietary fiber with reduced risk of CRC had a larger effect on tumors with detectable F nucleatum than those without F nucleatum.140”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [140] Mehta, 2017, Association of dietary patterns with risk of colorectal cancer subtypes classified by Fusobacterium nucleatum in tumor tissue, JAMA Oncol source
Not checked in the free run.
- Premisecitation
A meta-analysis associated each 100 g/day intake of red and processed meat with a 12% higher risk of colorectal cancer.
“A meta-analysis associated each 100 g/day intake of red and processed meat with a 12% higher risk of CRC.78”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [78] World Cancer Research Fund, American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer; 2017. Available at: https://www.wcrf.org/sites/default/files/Colorectal-Cancer-2017-Report.pdf. Accessed October 18, 2019.
Not checked in the free run.
- Premisecitation
A return to sedentary lifestyle for 6 weeks reversed changes in the gut microbiota observed after exercise training.
“Notably, the study also found that a return to sedentary lifestyle for 6 weeks reversed changes in the gut microbiota observed after exercise training, again indicating the sensitivity of the gut microbiome to physical activity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [113] Allen, 2018, Exercise alters gut microbiota composition and function in lean and obese humans, Med Sci Sports Exerc source
Not checked in the free run.
- Premisecitation
Compared with controls, colorectal cancer patients had lower abundances of Bifidobacterium and Lactobacillus spp. and other short-chain fatty acid-producing bacteria such as Clostridium, Roseburia, Lachnospiraceae, and Faecalibacterium prausnitzii.
“several studies have shown that compared with controls, patients with CRC had lower abundances of Bifidobacterium and Lactobacillus spp,16, 18 and other SCFA-producing bacteria, such as the genera Clostridium and Roseburia, the family Lachnospiraceae, and Faecalibacterium prausnitzii.15, 35, 37, 45, 53, 129”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [16] Thomas, 2019, Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation, Nat Med source
Not checked in the free run.
- cites [18] Feng, 2015, Gut microbiome development along the colorectal adenoma-carcinoma sequence, Nat Commun source
Not checked in the free run.
- cites [15] Ahn, 2013, Human gut microbiome and risk for colorectal cancer, J Natl Cancer Inst source
Not checked in the free run.
- cites [35] Zackular, 2014, The human gut microbiome as a screening tool for colorectal cancer, Cancer Prev Res (Phila) source
Not checked in the free run.
- cites [37] Vogtmann, 2016, Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing, PLoS One source
Not checked in the free run.
- cites [45] Wang, 2012, Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers, ISME J source
Not checked in the free run.
- cites [53] Shah, 2018, Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer, Gut source
Not checked in the free run.
- cites [129] Flemer, 2017, Tumour-associated and non-tumour-associated microbiota in colorectal cancer, Gut source
Not checked in the free run.
- Premisecitation
Cardiorespiratory fitness has been associated with higher fecal butyrate levels and increased abundances of butyrate-producing taxa including Clostridiales, Roseburia, Lachnospiraceae, and Erysipelotrichaceae.
“Cardiorespiratory fitness has also been associated with higher fecal levels of butyrate and increased abundances of butyrate-producing taxa, including Clostridiales, Roseburia, Lachnospiraceae, and Erysipelotrichaceae.111”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] Estaki, 2016, Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions, Microbiome source
Not checked in the free run.
- Premisecitation
A few cross-sectional studies reported that colorectal cancer patients had a lower abundance of butyrate-producing species and lower fecal butyrate levels than controls.
“a few cross-sectional studies reported that patients with CRC had a lower abundance of butyrate-producing species and lower fecal levels of butyrate than controls (Table 1).97, 133–135”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [97] Weir, 2013, Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults, PLoS One source
Not checked in the free run.
- cites [133] Lin, 2019, 1H NMR-based metabolomics reveal overlapping discriminatory metabolites and metabolic pathway disturbances between colorectal tumor tissues and fecal samples, Int J Cancer source
Not checked in the free run.
- cites [134] Lin, 2016, NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer, Oncotarget source
Not checked in the free run.
- cites [135] Monleón, 2009, Metabolite profiling of fecal water extracts from human colorectal cancer, NMR Biomed source
Not checked in the free run.
- Premisecitation
Some but not all cross-sectional studies associated higher fiber intake with increased fecal short-chain fatty acid levels and enrichment of short-chain fatty acid-producing bacteria such as Eubacterium rectale, Roseburia spp., and Faecalibacterium prausnitzii.
“Some but not all cross-sectional studies associated higher fiber intake with increased fecal levels of SCFAs and enrichment of SCFA-producing bacteria, such as Eubacterium rectale, Roseburia spp., and Faecalibacterium prausnitzii.126, 127”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [126] O’Keefe, 2015, Fat, fibre and cancer risk in African Americans and rural Africans, Nat Commun source
Not checked in the free run.
- cites [127] Chen, 2013, Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma, Am J Clin Nutr source
Not checked in the free run.
- Premisecitation
Fiber supplementation increased the concentration of butyrate in fecal samples.
“Fiber supplementation increased the concentration of butyrate in fecal samples.128”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128] So, 2018, Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis, Am J Clin Nutr source
Not checked in the free run.
- Premisecitation
In patients with colorectal adenomas, circulating deoxycholic acid levels were higher than in controls in studies from the 1990s.
“Studies in the 1990s reported higher circulating levels of deoxycholic acid in patients with colorectal adenomas than controls.156, 157”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [156] Bayerdorffer, 1995, Unconjugated secondary bile acids in the serum of patients with colorectal adenomas, Gut source
Not checked in the free run.
- cites [157] Bayerdorffer, 1993, Increased serum deoxycholic acid levels in men with colorectal adenomas, Gastroenterology source
Not checked in the free run.
- Premisecitation
A meta-analysis of fecal metagenomes found that colorectal cancer patients had higher levels of two bacterial genes regulating trimethylamine synthesis, cutC and cutD.
“A meta-analysis of metagenomes of fecal samples146 found patients with CRC to have higher levels of 2 bacterial genes that regulate TMA synthesis: choline TMA-lyase (cutC) and choline TMA-lyase-activating enzyme (cutD).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [146] Wirbel, 2019, Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer, Nat Med source
Not checked in the free run.
- Premisecitation
Some but not all prospective studies associated higher dietary and plasma levels of choline with increased risk of colorectal neoplasia.
“Some,147, 148 but not all,149–151 prospective studies have associated higher dietary and plasma levels of choline with increased risk of colorectal neoplasia.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [147] Nitter, 2014, Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC), Ann Oncol source
Not checked in the free run.
- cites [148] Cho, 2007, Dietary choline and betaine and the risk of distal colorectal adenoma in women, J Natl Cancer Inst source
Not checked in the free run.
- cites [149] Myte, 2016, Components of one-carbon metabolism other than folate and colorectal cancer risk, Epidemiology source
Not checked in the free run.
- cites [150] Lee, 2010, Choline and betaine intake and the risk of colorectal cancer in men, Cancer Epidemiol Biomarkers Prev source
Not checked in the free run.
- cites [151] Bae, 2014, Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study, Cancer Res source
Not checked in the free run.
- Premisecitation
Secondary bile acids and short-chain fatty acids act in opposite directions on inflammation in the colon.
“High levels of secondary bile acids and SCFAs have opposing effects on colon inflammation.170”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [170] Zeng, 2019, Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer, Int J Mol Sci source
Not checked in the free run.
- Interpretationcitation
Secondary bile acids may contribute to colorectal cancer development by generating reactive oxygen and nitrogen species that damage DNA and promote apoptosis resistance.
“Secondary bile acids might contribute to development of CRC because they generate reactive oxygen and nitrogen species that cause DNA damage and promote resistance to apoptosis.160”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [160] Bernstein, 2009, Bile acids as endogenous etiologic agents in gastrointestinal cancer, World J Gastroenterol source
Not checked in the free run.
- Premisecitation
A randomized controlled trial found that chronic ingestion of red meat, but not white meat or non-meat, increased plasma and urine levels of trimethylamine N-oxide.
“A randomized controlled trial found that chronic ingestion of red meat, but not white meat or non-meat, increased plasma and urine levels of TMAO.142”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [142] Wang, 2019, Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women, Eur Heart J source
Not checked in the free run.
- Premisecitation
Hydrogen sulfide-producing pathways are increased in fecal samples from colorectal cancer patients.
“H2S-producing pathways are increased in fecal samples from patients with CRC.20”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Yachida, 2019, Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer, Nat Med source
Not checked in the free run.
- Interpretationcitation
Sulfidogenic bacteria could help explain why African Americans have more colorectal cancer than Caucasians.
“Sulfidogenic bacteria might therefore contribute to the higher incidence of CRC in African Americans than Caucasians.166”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [166] Yazici, 2017, Race-dependent association of sulfidogenic bacteria with colorectal cancer, Gut source
Not checked in the free run.
- Premisecitation
People with gallstone disease and cholecystectomy have an increased risk of colorectal cancer.
“Patients with gallstone disease and cholecystectomy, who are believed to have higher concentrations of secondary bile acids due to continuous flow of bile acids to the bowel, have an increased risk of CRC.159”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [159] Shabanzadeh, 2017, Association between screen-detected gallstone disease and cancer in a cohort study, Gastroenterology source
Not checked in the free run.
- Premisecitation
People who consume more sulfur and sulfate appear to have a greater risk of inflammatory bowel disease.
“Higher intakes of sulfur and sulfate were associated with increased risk of IBD163”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [163] Owczarek, 2016, Diet and nutritional factors in inflammatory bowel diseases, World J Gastroenterol source
Not checked in the free run.
- Premisecitation
Among elderly men with an average age of 71, eating more organic sulfur was linked to greater amounts of hydrogen sulfide-producing Clostridium clostridioforme in stool.
“In a cohort of elderly men (mean age of 71 years), higher dietary intake of organic sulfur was associated with increased fecal abundance of H2S-producing Clostridium clostridioforme.167”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [167] Nguyen LH, Abu-Ali G, Mehta RS, et al. Dietary patterns, sulfur intake, and the abundance of sulfate-reducing bacteria. Paper presented at: Digestive Disease Week; May 18-21, 2019; San Diego, CA.
Not checked in the free run.
- Interpretationnone given
Eating red and processed meat could raise colorectal cancer risk by boosting bacterial output of secondary bile acids, hydrogen sulfide, and trimethylamine N-oxide.
“Red and processed meat might increase CRC risk by increasing bacterial production of secondary bile acids, H2S, and TMAO.”
Quote in the paperSubstantial claim - Premisecitation
Meat, particularly red meat, has high content of choline and carnitine, which are precursors to gut microbiota-mediated formation of trimethylamine and trimethylamine N-oxide.
“Meat, particularly red meat, has high content of choline and carnitine, which are precursors to gut microbiota-mediated formation of TMA and TMAO.141”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [141] Brown, 2018, Microbial modulation of cardiovascular disease, Nat Rev Microbiol source
Not checked in the free run.
- Premisecitation
Several taxonomic features associated with sequence variants of cutC were enriched in colorectal cancer patients, including Hungatella hathewayi, Clostridium asparagiforme, Klebsiella oxytoca, and Escherichia coli.
“Several taxonomic features associated with sequence variants of cutC were also found to be enriched in patients with CRC, including Hungatella hathewayi, Clostridium asparagiforme, Klebsiella oxytoca, and E coli.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [146] Wirbel, 2019, Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer, Nat Med source
Not checked in the free run.
- Interpretationreasoning
Exercise and fiber in the diet could lower colorectal cancer risk by raising levels of Akkermansia muciniphila and short-chain fatty acid-producing bacteria.
“Physical activity and dietary fiber might reduce risk of CRC by increasing the abundance of A muciniphila and SCFA-producing bacteria.”
Quote in the paperSubstantial claim - Premisecitation
The bai operon, which encodes 7α-dehydroxylation in Clostridium spp. needed for secondary bile acid synthesis, was enriched in fecal metagenomes from colorectal cancer patients.
“Moreover, the bai operon, encoding 7α-dehydroxylation in Clostridium spp. required for synthesis of secondary bile acids, was found to be enriched in metagenomes of fecal samples from patients with CRC.146”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [146] Wirbel, 2019, Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer, Nat Med source
Not checked in the free run.
- Premisecitation
High levels of trimethylamine N-oxide have been associated with increased risk of cardiovascular disease and mortality.
“High levels of TMAO have been associated with increased risk of cardiovascular disease and mortality.143–145”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [143] Shan, 2017, Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes, Am J Clin Nutr source
Not checked in the free run.
- cites [144] Heianza, 2017, Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies, J Am Heart Assoc
Not checked in the free run.
- cites [145] Schiattarella, 2017, Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis, Eur Heart J source
Not checked in the free run.
- Premisereasoning
Mouse studies using germ-free, gnotobiotic, and transgenic animals have revealed ways the gut microbiota could either promote or inhibit colorectal cancer.
“Analyses of gut microbiota of mice raised in germ-free or gnotobiotic conditions and transgenic mice, using techniques such as next-generation sequencing, microbial gene mutations, and microbial RNA-sequencing, have identified mechanisms by which the intestinal microbiota might contribute to or prevent development of CRC (Figure 1).”
Quote in the paperSubstantial claim - Premisecitation
The association between plasma trimethylamine N-oxide level and colorectal cancer risk was restricted to patients with low plasma vitamin B12 levels.
“In support of this hypothesis, the association between plasma level of TMAO and risk of CRC was restricted to patients with low plasma levels of vitamin B12.151”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [151] Bae, 2014, Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study, Cancer Res source
Not checked in the free run.
- Interpretationnone given
Diets high in fat and in red and processed meats raise the release of primary bile acids, which gut bacteria convert to secondary bile acids such as deoxycholic acid, lithocholic acid, and glycochenodeoxycholic acid.
“High fat content and consumption of red and processed meats increase secretion of primary bile acids that can be metabolized by the gut bacteria to secondary bile acid, including deoxycholic acid, lithocholic acid, and glycochenodeoxycholic acid.”
Quote in the paperSubstantial claim - Premisecitation
A milk-fat-rich diet expanded the immunogenic sulfite-reducing pathobiont Bilophila wadsworthia in both Il10−/− mice and mice with an intact Il10 gene.
“In Il10−/− mice and mice without disruption of this gene, a diet high in saturated (milk-derived) fat (MF) promoted expansion of the immunogenic sulfite-reducing pathobiont Bilophila wadsworthia, a member of the Deltaproteobacteria.174”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [174] Devkota, 2012, Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice, Nature source
Not checked in the free run.
- Premisecitation
Colon cancer patients' stool samples contain more hydrogen sulfide than those of controls.
“fecal samples from patients with colon cancer have higher concentrations of H2S than controls.164”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [164] Kanazawa, 1996, Factors influencing the development of sigmoid colon cancer: bacteriologic and biochemical studies, Cancer source
Not checked in the free run.
- Premisecitation
Several sulfidogenic bacteria, including Fusobacterium, Bilophila wadsworthia, and genera Lactococcus, Porphyromonas, Odoribacter, Bilophila, and Pyramidobacter, are enriched in tissue samples from colorectal cancer patients.
“Several sulfidogenic bacteria were found to be enriched in tissue samples from patients with CRC, including Fusobacterium, Bilophila wadsworthia, and the genera Lactococcus, Porphyromonas, Odoribacter, Bilophila, and Pyramidobacter.165, 166”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [165] Yazici, 2015, Bilophila wadsworthia is more abundant in the colonic microbiome of colorectal cancer cases compared to healthy controls, Gastroenterology
Not checked in the free run.
- cites [166] Yazici, 2017, Race-dependent association of sulfidogenic bacteria with colorectal cancer, Gut source
Not checked in the free run.
- Interpretationreasoning
Some elements of red and processed meat can be metabolized by gut bacteria to produce metabolites implicated in colorectal cancer.
“Some of these elements can be metabolized by the gut bacteria to produce metabolites that have been implicated in CRC.”
Quote in the paperNot a substantial claim - Premisecitation
Bifidobacterium improved tumor response to anti-PDCD1 antibodies by enhancing dendritic cell activity, CD8+ T cell priming, and their buildup in the tumor microenvironment.
“Bifidobacterium increased the response of tumors to antibodies against programmed cell death 1 (PDCD1), which increased dendritic cell function, priming of CD8+ T cells, and their accumulation in the tumor microenvironment.194”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [194] Sivan, 2015, Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy, Science source
Not checked in the free run.
- Premisecitation
Bacteroides thetaiotaomicron and B. fragilis correlate with better response to CTLA4 blockade, perhaps through interleukin 12-dependent Th1 immune responses.
“Bacteroides thetaiotaomicron and B fragilis have been associated with higher efficacy of agents that block cytotoxic T-lymphocyte associated protein 4 (CTLA4), possibly by affecting interleukin 12-dependent T-helper 1 cell-mediated immune responses.”
Quote in the paperNot a substantial claim - Premisecitation
Bacterial ribonucleotide metabolism changed the cytotoxicity of 5-fluorouracil and 5-fluoro-20-deoxyuridine by shifting regulatory metabolites that synergized with drug-induced DNA damage.
“Bacterial ribonucleotide metabolism affected the cytotoxic effects 5-fluorouracil and 5-fluoro-20-deoxyuridine by altering production of regulatory metabolites had synergistic effects with drug-induced DNA damage.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Tumor tissue from patients whose cancer returned after chemotherapy contained more Fusobacterium nucleatum.
“Patients with post-chemotherapy recurrence had a higher abundance of F nucleatum in tumor tissues.28, 193”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [28] Yu, 2017, Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy, Cell source
Not checked in the free run.
- cites [193] Deng, 2018, Comparison of microbiota in patients treated by surgery or chemotherapy by 16S rRNA sequencing reveals potential biomarkers for colorectal cancer therapy, Front Microbiol source
Not checked in the free run.
- Interpretationreasoning
Pathogens and chronic inflammation can weaken the intestinal barrier and make it more permeable.
“Microbial pathogens and chronic inflammation can compromise barrier function and enhance permeability.”
Quote in the paperSubstantial claim - Premisecitation
Salmonella's AvrA protein drives inflammation and colon tumor growth through activation of beta-catenin signaling to STAT3.
“The protein AvrA, produced by Salmonella, promotes inflammation and colon tumor development by activating beta-catenin signaling to STAT3.36, 180”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
Most epidemiologic evidence linking the gut microbiome to colorectal cancer risk comes from retrospective case-control studies using specimens from people who already had cancer or precursor lesions.
“Epidemiologic evidence for the effects of the gut microbiome on CRC risk comes from retrospective case–control studies of biospecimens collected from patients with established CRC or precursor lesions.”
Quote in the paperSubstantial claim - Premisecitation
Some bacterial species enhanced one drug's effect while reducing another's.
“Different bacterial species increased the response to 1 drug and decreased the effect of another.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
Bacteria that make hydrogen sulfide could drive intestinal inflammation and thereby raise the risk of colitis-associated cancer.
“H2S-producing bacteria might promote intestinal inflammation to increase the risk for colitis-associated cancer.”
Quote in the paperNot a substantial claim - Premisecitation
Repeated Salmonella enterica infection in C57BL/6J mice caused intestinal inflammation and gradually impaired protective mechanisms by inducing endogenous neuraminidase, which lowered intestinal alkaline phosphatase levels and its protective effects.
“In C57BL/6J mice, recurrent infection with Salmonella enterica promoted intestinal inflammation and progressively disabled protective mechanisms, inducing endogenous neuraminidase activity to reduce the abundance and protective effects of intestinal alkaline phosphatase.179”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [179] Yang, 2017, Recurrent infection progressively disables host protection against intestinal inflammation, Science source
Not checked in the free run.
- Premisecitation
In C. elegans, bacterial metabolism changes the effectiveness of 5-fluorouracil, 5-fluoro-20-deoxyuridine, and camptothecin.
“Bacterial metabolism was found to affect the efficacy of the anti-pyrimidine drugs 5-fluorouracil and 5-fluoro-20-deoxyuridine and the topoisomerase I inhibitor camptothecin in Caenorhabditis elegans 191, 192.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationcitation
Greater population-wide antibiotic exposure could help drive high rates of bacterial infection.
“Increases in population-wide exposure to antibiotics 177 might contribute to high rates of bacterial infection.178”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [177] Fleming-Dutra, 2016, Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011, JAMA source
Not checked in the free run.
- cites [178] Crum Cianflone, 2008, Salmonellosis and the GI tract: more than just peanut butter, Curr Gastroenterol Rep source
Not checked in the free run.
- Premisecitation
Adding stool microbiome data to risk-factor model scores or to screening tests like FOBT and FIT improves detection accuracy for advanced adenomas.
“Combining the fecal microbiome data with scores from risk factor-based models or results of screening tests (such as fecal occult blood test and fecal immunochemical test) increases the accuracy of detection for advanced adenomas.35, 186, 187”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [35] Zackular, 2014, The human gut microbiome as a screening tool for colorectal cancer, Cancer Prev Res (Phila) source
Not checked in the free run.
- cites [186] Wong, 2017, Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia, Gut source
Not checked in the free run.
- cites [187] Baxter, 2016, Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions, Genome Med source
Not checked in the free run.
- Premisecitation
Fusobacterium nucleatum makes colorectal cancer cells more resistant to chemotherapy.
“F nucleatum was promotes resistance of CRC cells to chemotherapy.28”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Yu, 2017, Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy, Cell source
Not checked in the free run.
- Premisecitation
Immunohistochemistry showed more AvrA protein in pre-cancerous colon tissue than in normal colon or tumor tissue.
“Expression of AvrA protein, detected by immunohistochemistry, was significantly higher in pre-cancer colon tissues than in normal human colon or tumor tissues, based on pathology differences.181”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [181] Lu, 2017, Presence of Salmonella AvrA in colorectal tumor and its precursor lesions in mouse intestine and human specimens, Oncotarget source
Not checked in the free run.
- Interpretationcitation
As colorectal cancer develops, epithelial and metabolic shifts could give some gut bacteria a competitive edge.
“The epithelial and metabolic changes that occur during development of CRC might provide a competitive advantage to a subset of intestinal bacteria.185”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [185] Boleij, 2013, The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease, Lancet Infect Dis source
Not checked in the free run.
- Premisecitation
Evidence is limited for a direct connection between particular gut bacteria or their virulence factors and sporadic colorectal cancer.
“Although dysbiosis is associated with chronic inflammation and production of carcinogenic metabolites, 175, 176 there is limited evidence to support a direct link between specific intestinal bacteria, their virulence factors, and sporadic CRC.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
Diet can be used to alter the gut microbiota of patients undergoing cancer treatment.
“Dietary interventions can be used to modulate the gut microbiota in patients receiving cancer therapy.”
Quote in the paperSubstantial claim - Interpretationnone given
Cross-sectional designs cannot establish whether diet and lifestyle changes cause shifts in gut microbiota, its metabolism, or immune effects.
“Cross-section studies cannot determine whether changes in diet and lifestyle cause changes in the intestinal microbiota, its metabolism, or its effects on the immune response.”
Quote in the paperSubstantial claim - Interpretationreasoning
Confounding makes it hard to correlate specific diet and lifestyle factors with the gut microbiome.
“Correlations among individual dietary and lifestyle factors and the gut microbiome are difficult to make due to confounding factors.”
Quote in the paperSubstantial claim - Premisenone given
Human data are scarce on how changes in gut microbiota affect colorectal cancer treatment.
“There are few human data on the role of effects of alterations in the gut microbiota in CRC treatment.”
Quote in the paperSubstantial claim - Interpretationreasoning
Preliminary findings suggest the microbiota may matter in colorectal cancer development, prevention, and treatment.
“Researchers have generated exciting preliminary data for the role of the microbiota in CRC development, prevention, and treatment.”
Quote in the paperSubstantial claim - Interpretationreasoning
Because most intervention studies are brief, they cannot assess how long-term exposures alter the gut microbiome in ways that affect colorectal cancer risk.
“The short duration of most intervention studies makes it impossible to examine the effects of alterations to the gut microbiome of long-term exposures that affect risk for CRC.”
Quote in the paperSubstantial claim - Premisenone given
Most evidence on environmental influences on the gut microbiome comes from cross-sectional or short-term intervention studies.
“Data on environmental factors that alter gut microbiome are mostly derived from cross-sectional or short-term interventional studies.”
Quote in the paperSubstantial claim
- May combine two claims. 66
- Classified as probably not a substantial claim. 7
May combine two claims.
PremisecitationFusobacterium nucleatum is associated with right-sided anatomic location, BRAF mutations, and hypermutation with microsatellite instability.
“Epidemiologic studies of patients with CRC or premalignant lesions have associated F nucleatum with specific clinical and molecular features, such as right-sided anatomic location, mutations in BRAF, and hypermutation with microsatellite instability.24–27”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [24] Ito, 2015, Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway, Int J Cancer source
Not checked in the free run.
- cites [25] Li, 2016, Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients, World J Gastroenterol source
Not checked in the free run.
- cites [26] Mima, 2016, Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis, Gut source
Not checked in the free run.
- cites [27] Tahara, 2014, Fusobacterium in colonic flora and molecular features of colorectal carcinoma, Cancer Res source
Not checked in the free run.
May combine two claims.
Premisenone givenStudies have found differences in intestinal microbiome composition between colorectal cancer cases and healthy controls, and individual microbes enriched or depleted in colorectal cancer patients.
“Studies have identified differences in compositions of intestinal microbiomes between CRC cases and healthy individuals (controls) as well as individual microbes that are enriched or depleted in microbiomes of patients with CRC.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenEvidence indicates that gut microbiome changes occur during early colorectal carcinogenesis and can identify individuals at risk for colorectal adenoma.
“Moreover, there is evidence that changes in the gut microbiome occur during early stages of colorectal carcinogenesis and can be used to identify individuals at risk for colorectal adenoma, the precursor lesion to CRC.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
InterpretationreasoningChanges in the microbiome may affect metabolism and immune function.
“This could be because changes of the microbiome affect metabolism and immune function.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningFeatures of the intestinal microbiome might be used for colorectal cancer screening and modified for chemoprevention and treatment.
“Based on these data, features of the intestinal microbiome might be used for CRC screening and modified for chemoprevention and treatment.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA meta-analysis of metagenomic data found higher richness in colorectal cancer microbiomes than controls, partly from expansions of species typically from the oral cavity.
“However, a meta-analysis of metagenomic data from different cohorts and populations found higher richness in microbiomes of CRC than controls, partly due to expansions of species typically derived from the oral cavity.16, 17”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [16] Thomas, 2019, Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation, Nat Med source
Not checked in the free run.
- cites [17] Sze, 2018, Leveraging existing 16S rRNA gene surveys to identify reproducible biomarkers in individuals with colorectal tumors, MBio source
Not checked in the free run.
May combine two claims.
InterpretationreasoningMicrobiome changes might be used as biomarkers for early colorectal cancer detection and to improve screening.
“Changes in the microbiome might therefore be used as biomarkers for early detection of CRC, to improve screening strategies.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHigher Fusobacterium nucleatum abundance, present in about 10%-15% of tumors, is associated with advanced disease stage, higher recurrence risk, and shorter survival.
“a higher abundance of F nucleatum (present in approximately 10%–15% of tumors) has been associated with advanced disease stage, higher risk of recurrence, and shorter patient survival times.23, 26, 28”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [23] Flanagan, 2014, Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome, Eur J Clin Microbiol Infect Dis source
Not checked in the free run.
- cites [26] Mima, 2016, Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis, Gut source
Not checked in the free run.
- cites [28] Yu, 2017, Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationHigher proportions of late-stage versus early-stage and right-side versus left-side tumors were enterotoxigenic Bacteroides fragilis positive.
“Significantly higher proportions of late-stage vs early stage, and of right-side vs left-side, tumors were ETBF positive.40, 43”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40] Boleij, 2015, The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients, Clin Infect Dis source
Not checked in the free run.
- cites [43] Viljoen, 2015, Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer, PLoS One source
Not checked in the free run.
May combine two claims.
PremisecitationIn colorectal cancer patients, Escherichia coli invade the colonic mucosa and become intracellular.
“In patients with CRC, E coli invade the colonic mucosa and become intracellular.47, 48”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [47] Swidsinski, 1998, Association between intraepithelial Escherichia coli and colorectal cancer, Gastroenterology source
Not checked in the free run.
- cites [48] Martin, 2004, Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer, Gastroenterology source
Not checked in the free run.
May combine two claims.
PremisecitationEnterotoxigenic Bacteroides fragilis abundance in fecal samples is lower than in mucosa because it colonizes colon epithelial crypts.
“Compared to mucosa, the abundance of ETBF in fecal samples is lower, because ETBF colonizes colon epithelial crypts.40, 44”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40] Boleij, 2015, The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients, Clin Infect Dis source
Not checked in the free run.
- cites [44] Toprak, 2006, A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer, Clin Microbiol Infect source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningEscherichia coli may not be shed into feces because they colonize the mucosa and reside within intestinal cells rather than the lumen.
“This might be because E coli colonize the mucosa and reside within intestinal cells, rather than the lumen, so they are not shed into feces.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSmokers have decreased relative abundance of Neisseria and increased relative abundance of Veillonellaceae.
“Smokers have a decreased relative abundance of Neisseria and increased relative abundance of Veillonellaceae families.58”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Kato, 2016, Oral microbiome and history of smoking and colorectal cancer, J Epidemiol Res
Not checked in the free run.
May combine two claims.
PremisecitationEscherichia coli strains with the pks gene, which mediates colibactin production, are found at higher frequency in individuals with colorectal cancer than without, in tumors than adjacent non-tumor tissue, and in late-stage than early-stage tumors.
“E coli strains with the polyketide synthase gene complex (pks) gene, which mediates production of genotoxin colibactin (called pks+ E coli), are found at higher frequency in individuals with than without CRC,49–52 in tumors than in adjacent non-tumor tissue,51 and in late-stage tumors compared with early-stage tumors.51”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [49] Arthur, 2012, Intestinal inflammation targets cancer-inducing activity of the microbiota, Science source
Not checked in the free run.
- cites [50] Buc, 2013, High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer, PLoS One source
Not checked in the free run.
- cites [51] Bonnet, 2014, Colonization of the human gut by E. coli and colorectal cancer risk, Clin Cancer Res source
Not checked in the free run.
- cites [52] Prorok-Hamon, 2014, Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer, Gut source
Not checked in the free run.
May combine two claims.
InterpretationcitationAlterations to the oral and intestinal microbiomes might each contribute to colorectal carcinogenesis through microbe dissemination and induction of inflammation.
“So, alterations to the oral and intestinal microbiomes might each contribute to colorectal carcinogenesis, via microbe dissemination and induction of inflammation.54, 55, 59,60.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [54] Yang, 2019, Prospective study of oral microbiome and colorectal cancer risk in low-income and African American populations, Int J Cancer source
Not checked in the free run.
- cites [55] Flemer, 2018, The oral microbiota in colorectal cancer is distinctive and predictive, Gut source
Not checked in the free run.
- cites [59] Lamont, 2018, The oral microbiota: dynamic communities and host interactions, Nat Rev Microbiol source
Not checked in the free run.
- cites [60] Sun, 2016, Gut microbiota, inflammation and colorectal cancer, Genes Dis source
Not checked in the free run.
May combine two claims.
PremisecitationSmoking and dietary iron were identified as potential risk factors, indicating a link between non-typhoid Salmonella infection and intestinal tumorigenesis.
“Smoking and dietary iron were identified as potential risk factors, indicating a link between non-typhoid Salmonella infection and intestinal tumoigenesis69.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Kato, 2013, Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk, Nutr Cancer source
Not checked in the free run.
May combine two claims.
PremisecitationThe proportions of enterotoxigenic Bacteroides fragilis-positive colorectal tumors differed between studies, 26% versus 89%, possibly due to assay or sample processing differences.
“However, the proportions of ETBF-positive colorectal tumors differed between these studies (26% vs 89%), possibly due to the differences in assays or sample processing methods.40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Boleij, 2015, The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients, Clin Infect Dis source
Not checked in the free run.
May combine two claims.
PremisecitationIndividuals with the highest level of physical activity have a 19% lower risk of colon cancer than those with the lowest level, but physical activity has not been associated with rectal cancer.
“Individuals with the highest level of physical activity have a 19% lower risk of colon cancer than individuals with the lowest level, but physical activity has not been associated with rectal cancer.78”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] World Cancer Research Fund, American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer; 2017. Available at: https://www.wcrf.org/sites/default/files/Colorectal-Cancer-2017-Report.pdf. Accessed October 18, 2019.
Not checked in the free run.
May combine two claims.
PremisecitationAkkermansia muciniphila correlated with better metabolic parameters, including lower fasting plasma glucose, lower plasma triglycerides, and improved insulin response.
“The bacteria correlated with better metabolic parameters, including lower fasting level of plasma glucose, lower level of plasma triglycerides, and improved insulin response.100”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Shoaie, 2015, Quantifying diet-induced metabolic changes of the human gut microbiome, Cell Metab source
Not checked in the free run.
May combine two claims.
PremisecitationEcological analysis revealed more co-exclusive correlations between fungi and bacteria in fecal samples from colorectal cancer patients than controls, supporting preclinical findings of an antagonistic relationship between bacteria and fungi during colorectal cancer development.
“Ecological analysis revealed more co-exclusive correlations between fungi and bacteria in fecal samples from patients with CRC than controls,73 supporting the preclinical findings for an antagonistic relationship between bacteria and fungi during CRC development.75”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [73] Coker, 2019, Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer, Gut source
Not checked in the free run.
- cites [75] Malik, 2018, SYK-CARD9 signaling axis promotes gut fungi-mediated inflammasome activation to restrict colitis and colon cancer, Immunity source
Not checked in the free run.
May combine two claims.
PremisecitationCompared with controls, colorectal cancer cases had increased diversity in bacteriophage viromes, associated with reduced bacterial diversity, and modest enrichment of specific viral taxa such as Inovirus and Tunalikevirus.
“Compared to controls, CRC cases had increased diversity in bacteriophage viromes, associated with reduced bacterial diversity, and modest enrichment of specific viral taxa, such as members of Inovirus and Tunalikevirus, whose bacterial hosts have been implicated in CRC”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [72] Nakatsu, 2018, Alterations in enteric virome are associated with colorectal cancer and survival outcomes, Gastroenterology source
Not checked in the free run.
- cites [74] Hannigan, 2018, Diagnostic potential and interactive dynamics of the colorectal cancer virome, MBio source
Not checked in the free run.
May combine two claims.
PremisecitationDistinct mycobiome profiles were identified in colorectal cancer patients versus controls and in early- versus late-stage colorectal cancer.
“Distinct mycobiome profiles were identified in patients with CRC vs controls and in patients with early- vs late-stage CRC.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Coker, 2019, Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationA bidirectional Mendelian randomization analysis provided genetic evidence that increased intestinal short-chain fatty acid production improves insulin responses and reduces abnormalities in short-chain fatty acid production or absorption and risk of type 2 diabetes.
“A bidirectional Mendelian randomization analysis provided genetic evidence that increased intestinal production of SCFAs improves patient responses to insulin and reduces abnormalities in the production or absorption of SCFAs and risk of type 2 diabetes.87”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [87] Sanna, 2019, Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases, Nat Genet source
Not checked in the free run.
May combine two claims.
PremisecitationHigher body mass index is associated with increased blood levels of lipopolysaccharide and lipopolysaccharide-binding protein, whereas weight loss reduces circulating levels of both.
“Higher BMIs have been associated with increased blood levels of LPS and LPS-binding protein (LBP), whereas weight loss reduces circulating LPS and LBP levels.102–104”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [102] Yang, 2016, Circulating biomarkers of gut barrier function: correlates and nonresponse to calcium supplementation among colon adenoma patients, Cancer Epidemiol Biomarkers Prev source
Not checked in the free run.
- cites [103] Moreno-Navarrete, 2012, Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance, Int J Obes (Lond) source
Not checked in the free run.
- cites [104] Lassenius, 2011, Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation, Diabetes Care source
Not checked in the free run.
May combine two claims.
PremisecitationA cross-sectional study found that patients with adenomas had higher blood lipopolysaccharide levels than controls, and patients with villous adenomas had higher levels than patients with only tubular adenomas.
“A cross-sectional study found that patients with adenomas had higher blood levels of LPS than controls, and that patients whose adenomas had villous features had higher levels of LPS than patients with only tubular adenomas.105”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [105] Kang, 2013, Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas, BMC Cancer source
Not checked in the free run.
May combine two claims.
PremisecitationBifidobacterium and Lactobacillus spp. produce lactate and acetate and can increase butyrate production through cross-feeding interactions with butyrate-producing species such as Eubacterium rectale.
“Bifidobacterium and Lactobacillus spp. produce lactate and acetate and can also increase production of butyrate through cross-feeding interactions with the butyrate-producing species, such as Eubacterium rectale.130–132”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [130] Flint, 2015, Links between diet, gut microbiota composition and gut metabolism, Proc Nutr Soc source
Not checked in the free run.
- cites [131] Belenguer, 2006, Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut, Appl Environ Microbiol source
Not checked in the free run.
- cites [132] Duncan, 2004, Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product, Appl Environ Microbiol source
Not checked in the free run.
May combine two claims.
PremisecitationFiber supplementation enriched Bifidobacterium and Lactobacillus spp., with no effect on other common short-chain fatty acid producers except increases in Roseburia spp. and Faecalibacterium prausnitzii in parallel rather than crossover trials.
“Fiber supplementation was found to enrich Bifidobacterium and Lactobacillus spp., whereas no effect was found on the other common SCFA producers except for increases in Roseburia spp. and F prausnitzii in parallel (rather than crossover) trials.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [128] So, 2018, Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis, Am J Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationFiber is fermented by bacteria to produce short-chain fatty acids, which regulate the immune system and metabolism and reduce colorectal cancer risk.
“Fiber is fermented by bacteria to produce SCFAs, which regulate the immune system and metabolism and reduce risk of CRC.6, 88, 94, 123–125”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [6] Song, 2019, Environmental factors, gut microbiota, and colorectal cancer prevention, Clin Gastroenterol Hepatol source
Not checked in the free run.
- cites [88] Koh, 2016, From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites, Cell source
Not checked in the free run.
- cites [94] Bultman, 2014, Molecular pathways: gene-environment interactions regulating dietary fiber induction of proliferation and apoptosis via butyrate for cancer prevention, Clin Cancer Res source
Not checked in the free run.
- cites [123] Ploger, 2012, Microbial butyrate and its role for barrier function in the gastrointestinal tract, Ann N Y Acad Sci source
Not checked in the free run.
- cites [124] Makki, 2018, The impact of dietary fiber on gut microbiota in host health and disease, Cell Host Microbe source
Not checked in the free run.
- cites [125] Bhatt, 2017, The role of the microbiome in cancer development and therapy, CA Cancer J Clin
Not checked in the free run.
May combine two claims.
InterpretationcitationDifferences in food sources of fiber between European and American diets and relatively low fiber intake in US cohorts might explain inconsistent results.
“This might be due to differences in the food sources of fiber between European and American diets (mostly cereals vs fruits and vegetables) and the relatively low fiber intake in the US cohorts, which might not have achieved an effective threshold.3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Song, 2015, Nutrients, foods, and colorectal cancer prevention, Gastroenterology source
Not checked in the free run.
May combine two claims.
PremisecitationIn some but not all randomized controlled trials, increased whole grain consumption was associated with higher abundance of short-chain fatty acid-producing bacteria such as Roseburia and Lachnospira, lower abundance of proinflammatory Enterobacteriaceae, and higher fecal short-chain fatty acid levels.
“In some136, 137 but not all138, 139 randomized controlled trials, increased consumption of whole grains was associated with higher abundance of SCFA-producing bacteria, such as Roseburia and Lachnospira, lower abundance of proinflammatory Enterobacteriaceae, and higher levels of fecal SCFAs through anti-inflammaion.136”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [136] Vitaglione, 2015, Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber, Am J Clin Nutr source
Not checked in the free run.
- cites [137] Martinez, 2013, Gut microbiome composition is linked to whole grain-induced immunological improvements, ISME J source
Not checked in the free run.
- cites [138] Vuholm, 2017, Whole-grain rye and wheat affect some markers of gut health without altering the fecal microbiota in healthy overweight adults: a 6-week randomized trial, J Nutr
Not checked in the free run.
- cites [139] Roager, 2019, Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial, Gut source
Not checked in the free run.
May combine two claims.
InterpretationreasoningGiven metagenomic enrichment of choline-metabolizing pathways in colorectal cancer patients, these findings support benefits of physical activity in reducing trimethylamine N-oxide production and colorectal cancer risk.
“Give the finding of metagenomic enrichment of choline-metabolizing pathways in patients with CRC, 16 these findings support the benefits of physical activity in reducing production of TMAO and risk of CRC.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Thomas, 2019, Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation, Nat Med source
Not checked in the free run.
May combine two claims.
PremisecitationThe European Prospective Investigation into Cancer and Nutrition cohort consistently found an association between fiber intake and reduced colorectal cancer risk, in contrast to most US studies.
“In contrast to most US studies, which reported no association,116–119 the European Prospective Investigation into Cancer and Nutrition cohort consistently found an association between fiber intake and reduced risk CRC.120–122”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [116] Kunzmann, 2015, Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, Am J Clin Nutr source
Not checked in the free run.
- cites [117] Higginbotham, 2004, Dietary glycemic load and risk of colorectal cancer in the Women’s Health Study, J Natl Cancer Inst source
Not checked in the free run.
- cites [118] Michels, 2005, Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men, Cancer Epidemiol Biomarkers Prev source
Not checked in the free run.
- cites [119] He, 2019, Dietary intake of fiber, whole grains and risk of colorectal cancer: an updated analysis according to food sources, tumor location and molecular subtypes in two large US cohorts, Int J Cancer source
Not checked in the free run.
- cites [120] Bingham, 2003, Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study, Lancet source
Not checked in the free run.
- cites [121] Bingham, 2005, Is the association with fiber from foods in colorectal cancer confounded by folate intake?, Cancer Epidemiol Biomarkers Prev source
Not checked in the free run.
- cites [122] Murphy, 2012, Dietary fibre intake and risks of cancers of the colon and rectum in the European Prospective Investigation into Cancer and Nutrition (EPIC), PloS One source
Not checked in the free run.
May combine two claims.
PremisecitationEight weeks of mixed aerobic and resistance exercise training improved cardiorespiratory fitness and body composition but did not produce significant changes in the fecal microbiome or metabolites.
“In the second study, 8 weeks of mixed aerobic and resistance exercise training improved cardiorespiratory fitness and body composition, but did not produce significant changes in the fecal microbiome114 or metabolites.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [114] Cronin, 2018, A prospective metagenomic and metabolomic analysis of the impact of exercise and/or whey protein supplementation on the gut microbiome of sedentary adults, mSystems source
Not checked in the free run.
May combine two claims.
PremisecitationConsumption of whole-grain wheat increases the fecal concentration of ferulic acid and the serum concentration of dihydroferulic acid, a metabolite derived from ferulic acid by Lactobacillus and Bifidobacterium.
“Consumption of whole-grain wheat increases the fecal concentration of ferulic acid (the most abundant phenolic compound in whole grains) and serum concentration of dihydroferulic acid (a metabolite derived from ferulic acid by Lactobacillus and Bifidobacterium).136”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] Vitaglione, 2015, Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber, Am J Clin Nutr source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSynergistic mechanisms might augment production of beneficial metabolites and account for the ability of whole grains to reduce colorectal cancer risk compared with other food sources of dietary fiber.
“Given the shared microbes in the synthesis of SCFA and dihydroferulic acid, synergistic mechanisms might augment the production of beneficial metabolites. These might account for ability of whole grains to reduce CRC risk compared with other food sources of dietary fiber.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationEating more fiber might lessen the cancer-promoting effects of Fusobacterium nucleatum by restoring immune surveillance.
“It is possible that higher intake of fiber could reduce the carcinogenic effects of F nucleatum by restoring effective immunosurveillance.173”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [173] Mehta, 2018, Stability of the human faecal microbiome in a cohort of adult men, Nat Microbiol source
Not checked in the free run.
- Rests on an assumption: Fiber controls immune responses and Fusobacterium nucleatum levels.
May combine two claims.
PremisecitationSerum glycochenodeoxycholic acid concentration was associated with colorectal cancer risk in women but not men in a large prospective serum metabolome study.
“A large prospective study of serum metabolomes associated concentration of glycochenodeoxycholic acid with CRC risk in women but not in men.158”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158] Cross, 2014, A prospective study of serum metabolites and colorectal cancer risk, Cancer source
Not checked in the free run.
May combine two claims.
PremisecitationChanges in bile acid composition and concentrations are associated with metabolic disorders and inflammatory bowel disease, which increase colorectal cancer risk.
“Changes in bile acid composition and concentrations have been associated with metabolic disorders and IBD, which increases risk for CRC.161, 162”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [161] Staels, 2009, Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration, Diabetes Care source
Not checked in the free run.
- cites [162] Franzosa, 2019, Gut microbiome structure and metabolic activity in inflammatory bowel disease, Nat Microbiol source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSeveral pathways are thought to connect the gut microbiota to colorectal cancer, including chronic inflammation, immune dysfunction, higher serum LPS, secondary bile acids, and leaky gut.
“Chronic inflammation, dysfunction of immunity, increased serum levels of LPS, secondary bile acids, and leaky gut are representative pathways that link the gut microbiota with CRC (Figure 1).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChanges in trimethylamine N-oxide and choline were associated with increased insulin sensitivity in a weight-loss intervention study of obese individuals.
“Changes in TMAO and choline associated with increased insulin sensitivity in a weight-loss intervention study of obese individuals.155”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [155] Heianza, 2019, Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial, Gut source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe ultimate effect of choline might depend on whether it is distributed in the circulation for one-carbon metabolism or in the gut for microbial trimethylamine N-oxide production.
“so the ultimate effect of choline might depend on its distribution in the circulation for 1-carbon metabolism vs in the gut for microbial production of TMAO.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Song, 2015, Nutrients, foods, and colorectal cancer prevention, Gastroenterology source
Not checked in the free run.
May combine two claims.
PremisecitationA higher plasma level of trimethylamine N-oxide was associated with increased colorectal cancer risk, but this finding was not replicated.
“A higher plasma level of TMAO was associated with an increased risk of CRC,151 but this finding was not replicated.152”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [151] Bae, 2014, Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study, Cancer Res source
Not checked in the free run.
- cites [152] Guertin, 2017, Serum trimethylamine N-oxide, carnitine, choline, and betaine in relation to colorectal cancer risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study, Cancer Epidemiol Biomarkers Prev source
Not checked in the free run.
May combine two claims.
PremisecitationButyrate raises vitamin D receptor mRNA and protein in the intestine, lessens dysbiosis, and triggers Paneth cell autophagy, which suppresses chronic inflammation.
“Butyrate increases intestinal expression of vitamin D receptor mRNA and protein, reduces intestinal dysbiosis, and activates the autophagy response of Paneth cells to inhibit chronic inflammation.172”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [172] Wu, 2015, Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationHigher levels of choline and trimethylamine N-oxide have been linked to metabolic disturbances that might increase colorectal cancer risk, including higher body mass index, greater visceral adiposity, insulin resistance, diabetes, and fatty liver.
“Higher levels of choline and TMAO have been linked to a spectrum of metabolic disturbances that might increase CRC risk, including higher BMI, greater visceral adiposity, insulin resistance, diabetes, and fatty liver.153, 154”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [153] Randrianarisoa, 2016, Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans, Sci Rep source
Not checked in the free run.
- cites [154] Barrea, 2018, Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome, Nutrients source
Not checked in the free run.
May combine two claims.
PremisecitationCompared with Caucasians, African Americans show much greater amounts of sulfur-reducing bacteria and B. wadsworthia, and this difference persists after diet is accounted for.
“Interestingly, African Americans have substantially higher abundances of sulfur-reducing bacteria and B wadsworthia than Caucasians, even after adjusting for dietary variables.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [166] Yazici, 2017, Race-dependent association of sulfidogenic bacteria with colorectal cancer, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationGut hydrogen sulfide is produced either by sulfur-reducing bacteria from inorganic sulfur (sulfate and sulfite) used as a preservative in processed meat or by fermentative bacteria metabolizing organic sulfur compounds enriched in animal products such as red meat.
“Hydrogen sulfide (H2S) is generated in the gut either by sulfur-reducing bacteria from inorganic sulfur (sulfate and sulfite) that is routinely used as a preservative in processed meat or by fermentative bacteria that metabolize organic sulfur compounds that are enriched in animal products such as red meat.3”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Song, 2015, Nutrients, foods, and colorectal cancer prevention, Gastroenterology source
Not checked in the free run.
May combine two claims.
PremisecitationDiets linked to more sulfur-producing bacteria in stool were tied to a higher risk of cancer in the distal colon, but not the proximal colon.
“we associated dietary patterns with higher fecal abundances of sulfur-producing and increased risk of distal CRC, but not proximal colon cancer.167”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [167] Nguyen LH, Abu-Ali G, Mehta RS, et al. Dietary patterns, sulfur intake, and the abundance of sulfate-reducing bacteria. Paper presented at: Digestive Disease Week; May 18-21, 2019; San Diego, CA.
Not checked in the free run.
May combine two claims.
PremisecitationMore short-chain fatty acids in stool correlate with more memory T cells in blood, lower inflammatory cytokines like tumor necrosis factor, and higher anti-inflammatory cytokines like interleukin 10.
“Higher levels of fecal SCFAs were associated with increased numbers of memory T cells in blood,171 reduced levels of inflammatory cytokines (such as tumor necrosis factor), and increased levels of anti-inflammatory cytokines (such as interleukin 10).136”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [171] Vanegas, 2017, Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults, Am J Clin Nutr source
Not checked in the free run.
- cites [136] Vitaglione, 2015, Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber, Am J Clin Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationAn analysis of eight diverse fecal shotgun metagenomic studies found evidence of increased secondary bile acid production in colorectal cancer patients, suggesting that cancer-associated microbes are metabolically linked to a diet rich in fat and meat.
“A recent analysis of 8 geographically and technically diverse fecal shotgun metagenomic studies found evidence for increased production of secondary bile acids in patients with CRC, indicating a metabolic link between cancer-associated microbes and a fat- and meat-rich diet. 146”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [146] Wirbel, 2019, Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer, Nat Med source
Not checked in the free run.
May combine two claims.
Interpretationnone givenObesity could drive colorectal carcinogenesis by causing systemic inflammation through LPS and by reducing short-chain fatty acid-producing bacteria.
“For example, obesity might promote colorectal carcinogenesis via LPS-mediated systemic inflammation and depletion of SCFA-producing bacteria.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThe carcinogenic effect of red and processed meat might be mediated by preservatives such as nitrates and nitrites, additives such as emulsifiers, chemicals produced during processing and cooking such as heterocyclic amines and polycyclic aromatic hydrocarbons, or nutrients enriched in meats such as heme iron, sulfur, and choline.
“The carcinogenic effect might be mediated by preservatives in red and processed (such as nitrates and nitrites), other additives (such as emulsifiers), chemicals produced during meat processing and cooking (such as heterocyclic amines and polycyclic aromatic hydrocarbons), or nutrients enriched in meats (such as heme iron, sulfur, and choline).3”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Song, 2015, Nutrients, foods, and colorectal cancer prevention, Gastroenterology source
Not checked in the free run.
May combine two claims.
Interpretationnone givenBoth genetic variants and environmental exposures add to dysbiosis and colorectal cancer development.
“Genetic variants, along with environmental factors, also contribute to contribute to dysbiosis and development of CRC.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAkkermansia muciniphila and Faecalibacterium correlate with better anti-PDCD1 efficacy, perhaps by drawing more T cells into tumors and enhancing their activity.
“A muciniphila195 and Faecalibacterium196 have been associated with greater efficacy of PDCD1 blocking agents—possibly by increasing recruitment of T cells to tumors and their functions there.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [195] Routy, 2018, Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors, Science source
Not checked in the free run.
- cites [196] Gopalakrishnan, 2018, Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients, Science source
Not checked in the free run.
May combine two claims.
InterpretationreasoningFecal microbiome changes seen in colorectal cancer patients also appear in adenoma patients, suggesting a possible screening use for people at risk.
“Alterations in the fecal microbiomes of patients with CRC have also been observed in patients with colorectal adenoma—these might be used in screening for individuals at risk for CRC.”
Quote in the paperSubstantial claim- Rests on an assumption: Most colorectal cancer screening methods have poor ability to detect proximal lesions.
May combine two claims.
PremisecitationIn mice, Citrobacter rodentium-induced colonic crypt hyperplasia comes with changes in beta-catenin and Notch signaling, barrier function, and fecal dysbiosis, and leads to colon tumors.
“Mice with Citrobacter rodentium-induced colonic crypt hyperplasia have alterations in beta-catenin and Notch signaling, intestinal barrier function, and fecal dysbiosis, resulting in development of colon tumors.182, 183”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [182] Ahmed, 2012, Critical roles of Notch and Wnt/β-catenin pathways in the regulation of hyperplasia and/or colitis in response to bacterial infection, Infect Immun source
Not checked in the free run.
- cites [183] Ahmed, 2018, Enteric infection coupled with chronic Notch pathway inhibition alters colonic mucus composition leading to dysbiosis, barrier disruption and colitis, PLoS One source
Not checked in the free run.
May combine two claims.
InterpretationreasoningMovement of microbial products and metabolites, higher serum LPS, and immune activation all drive dysbiosis, barrier failure, and inflammation.
“Translocation of microbial products, metabolites, increased serum LPS, and immune activation promote dysbiosis, barrier failure, and inflammation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBioinformatic and functional work suggests Fusobacterium nucleatum triggers innate immunity through TLR4 and MYD88, causing loss of certain microRNAs, which turns on autophagy and drives chemoresistance in colorectal cancer patients.
“Bioinformatic and functional studies indicated that F nucleatum activates innate immune responses, via TLR4 and MYD88, resulting in loss of specific microRNAs. This resulted in activation of autophagy activation and promotion of chemoresistance in patients with CRC.28”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Yu, 2017, Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy, Cell source
Not checked in the free run.
May combine two claims.
PremisecitationStool microbiome testing detects adenomas with moderate accuracy, with validation AUCs between 0.55 and 0.67, which is below its accuracy for colorectal cancer.
“Fecal microbiome analysis identifies patients with adenomas with reasonable levels of accuracy (area under receiver operating curves ranging from 0.55 to 0.67 in validation studies), although this is a lower value than for detection of CRC.16, 18, 186–188”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [16] Thomas, 2019, Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation, Nat Med source
Not checked in the free run.
- cites [18] Feng, 2015, Gut microbiome development along the colorectal adenoma-carcinoma sequence, Nat Commun source
Not checked in the free run.
- cites [186] Wong, 2017, Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia, Gut source
Not checked in the free run.
- cites [187] Baxter, 2016, Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions, Genome Med source
Not checked in the free run.
- cites [188] Dadkhah, 2019, Gut microbiome identifies risk for colorectal polyps, BMJ Open Gastroenterol source
Not checked in the free run.
May combine two claims.
Premisenone givenMultiple studies suggest gut microbiota can shape immunotherapy efficacy, but no evidence yet links it to immunotherapy for colorectal cancer.
“Several studies have indicated that the gut microbiota can determine the efficacy of cancer immunotherapy, although there is no evidence for its effects on immunotherapy for CRC.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFusobacterium nucleatum raises microRNA 21 in colorectal cancer cells through TLR4 signaling involving MYD88 and nuclear factor-kappa B, which boosts their proliferation.
“F nucleatum induce expression of microRNA 21 by CRC cells by activating TLR4 signaling via MYD88 and nuclear factor-kappa B. This increased proliferation of the CRC cells.184”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [184] Yang, 2017, Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of microRNA-21, Gastroenterology source
Not checked in the free run.
May combine two claims.
PremisecitationThis Bilophila wadsworthia increase came from a milk-fat diet shifting liver bile acid conjugation from glycocholic to taurocholic acid, which aids solubilization of the more hydrophobic milk-fat diet.
“The Bilophila wadsworthia expansion resulted from a MF diet-induced shift in hepatic conjugation of bile acids, from glycocholic to taurocholic acid, which helps solubilize the more hydrophobic MF diet.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [174] Devkota, 2012, Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice, Nature source
Not checked in the free run.
May combine two claims.
InterpretationreasoningCertain bacterial strains seem to disturb the gut microbiome and drive inflammation, raising the risk of inflammatory bowel disease and colon carcinogenesis.
“Specific strains of bacteria therefore appear to disrupt the intestinal microbiome and promote inflammation to increase risk for IBD and colon carcinogenesis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMeasuring fecal Fusobacterium nucleatum alongside FIT doubled sensitivity for advanced adenomas, and an independent validation cohort showed a similar gain.
“For example, addition of fecal F nucleatum quantitation to fecal immunochemical test, which has suboptimal sensitivity in detecting adenomas, doubled the sensitivity for detection of advanced adenomas. A similar improvement was observed in an independent validation cohort.186”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [186] Wong, 2017, Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationChanges in gut microbiota can change how well CpG-oligonucleotide immunotherapy and oxaliplatin work; antibiotic-treated or germ-free mice responded less to both.
“Both therapies had reduced efficacy in mice given antibiotics or germ-free mice, which had lower production of cytokines and less tumor necrosis after CpG-oligonucleotide administration and reduced production of reactive oxygen species and cytotoxicity after chemotherapy compared.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [190] Iida, 2013, Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment, Science source
Not checked in the free run.
May combine two claims.
PremisecitationIn colorectal cancer patients, greater consumption of fiber, marine omega-3s, vitamin D, calcium, coffee, or a plant-based low-carbohydrate diet has been linked to longer survival.
“Higher intake of nutrients such as fiber,199 marine omega-3 fatty acid,200–202 vitamin D,203–205 or calcium,203 or coffee206, 207 or a plant-based low-carbohydrate diet207 has been associated with increased survival times of patients with CRC.”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [199] Song, 2018, Fiber intake and survival after colorectal cancer diagnosis, JAMA Oncol source
Not checked in the free run.
- cites [200] Cockbain, 2012, Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer, Gut source
Not checked in the free run.
- cites [201] Song, 2017, Marine omega-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis, Gut source
Not checked in the free run.
- cites [202] Van Blarigan, 2018, Dietary fat intake after colon cancer diagnosis in relation to cancer recurrence and survival: CALGB 89803 (Alliance), Cancer Epidemiol Biomarkers Prev source
Not checked in the free run.
- cites [203] Yang, 2019, Calcium intake and survival after colorectal cancer diagnosis, Clin Cancer Res source
Not checked in the free run.
- cites [204] Zgaga, 2014, Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer, J Clin Oncol source
Not checked in the free run.
- cites [205] Vaughan-Shaw, 2020, Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response, Gut source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEach year in the US, over a million people get Salmonella from food, mostly eggs, meats, dairy, and other contaminated non-animal foods.
“More than 1 million people in the US acquire Salmonella infection annually as a foodborne illness mainly from eggs, meats, dairy, and other contaminated non-animal foods.178”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [178] Crum Cianflone, 2008, Salmonellosis and the GI tract: more than just peanut butter, Curr Gastroenterol Rep source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningThose C. elegans studies did not include colorectal cancer patients or mouse models.
“However, no patients or mouse models of CRC were used in these studies.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe gut microbiota influences how cancer therapy works and how likely toxic side effects are, but human evidence remains limited.
“In addition to affecting CRC development, the gut microbiota modulates the response to cancer therapy and susceptibility to toxic side effects, although there is only limited evidence from patients (for reviews, see 8, 189).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationcitationBecause many of these factors affect immunity and the microbiota, they could improve the effectiveness and lower the side effects of immunotherapies or other treatments.
“Many of these factors have immunomodulatory and microbiota-modifying effects, so they might increase the efficacy and reduce the adverse effects of immunotherapies or other therapeutic agents.208”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [208] Song, 2018, The potential role of exercise and nutrition in harnessing the immune system to improve colorectal cancer survival, Gastroenterology source
Not checked in the free run.
May combine two claims.
PremisecitationCertain bacteria correlate with protection from immune checkpoint inhibitor-associated colitis, and fecal microbiota transplantation could be a treatment for it.
“Moreover, specific bacteria have been associated with resistance to the development of immune checkpoint inhibitor-associated colitis,197 and fecal microbiota transplants might be used to treat this form of colitis.198”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [197] Dubin, 2016, Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis, Nat Commun source
Not checked in the free run.
- cites [198] Wang, 2018, Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis, Nat Med source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningClinical studies have often been small, mostly under 100 cases, and probably lacked power to detect predictive signals among the many sequencing read counts.
“Moreover, clinical studies have been limited by small sample sizes (mostly <100 cases), likely underpowered to identify predictive signals from hundreds to thousands of reads counts generated by high-throughput sequencing.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationWhether the microbial changes found in colorectal carcinogenesis are causal or consequential remains unresolved.
“It is not clear whether the identified microbial alterations are a cause or consequence of colorectal carcinogenesis.209”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [209] Tjalsma, 2012, A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects, Nat Rev Microbiol source
Not checked in the free run.
The paper relies on this without support.
Colorectal cancer-related risk factors are associated with specific changes in the intestinal microbiota, even though there is no direct evidence for this.
“Although there is no direct evidence, CRC-related risk factors have been associated with specific changes in the intestinal microbiota.”
The paper relies on this without support.
The composition of the microbiota is determined by genetic, environmental, and dietary factors.
“The composition of microbiota is determined by genetic, environmental, and dietary factors.”
The paper relies on this without support.
Fiber controls immune responses and Fusobacterium nucleatum levels.
“Fiber regulates the immune response and levels of F nucleatum.”
The paper relies on this without support.
Short-chain fatty acid-producing bacteria such as Roseburia and Lachnospira lower colorectal cancer risk.
“SCFA-producing bacteria, such as Roseburia and Lachnospira, reduce risk of CRC.”
The paper relies on this without support.
Most colorectal cancer screening methods have poor ability to detect proximal lesions.
“Most screening methods have limited abilities to detect proximal lesions (such as the fecal immunohistochemical test, flexible sigmoidoscopy, and colonoscopy), so it is important to determine whether analyses of fecal microbiomes can improve the sensitivity of detection of proximal colon neoplasias.”
The paper relies on this without support.
The intestine must maintain commensal microbes and a high load of bacterial products while responding quickly to pathogens.
“The intestine must maintain commensal microbes and a high load of bacterial products, but swiftly respond to pathogens that threaten its integrity.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Lack of a "healthy" microbiota is associated with many forms of disease, including metabolic diseases, gastrointestinal cancer, inflammatory bowel disease, renal disease, and neurodegenerative diseases associated with aging.
“Lack of a “healthy” microbiota is associated with many forms of disease (19–24), such as metabolic diseases (obesity, type 2 diabetes), gastrointestinal cancer, inflammatory bowel disease, and renal disease, as well as neurodegenerative diseases (NDs) associated with aging, in which the activity and composition of the gut microbiota change during the life cycle.”
From Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis (2023) · cites this paper as [23]
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · see citing works
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · see citing works
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070 · see citing works
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · see citing works
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · see citing works
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · see citing works
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · see citing works
Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · see citing works
Colorectal cancer statistics, 2017
Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester, R. G. S., Barzi, A., & Jemal, A. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21395 · Cited by 3,807 · see citing works
Environment dominates over host genetics in shaping human gut microbiota
Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P. I., Godneva, A., Kalka, I. N., Bar, N., et al. (2018) · Nature · doi:10.1038/nature25973 · Cited by 2,859 · see citing works
The impact of dietary fiber on gut microbiota in host health and disease
Makki, K., Deehan, E. C., Walter, J., & Bäckhed, F. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.012 · Cited by 2,517 · see citing works
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., et al. (2018) · Science · doi:10.1126/science.aao5774 · Cited by 2,304 · see citing works
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263 · see citing works
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251 · see citing works
The Oral Microbiota: Dynamic Communities and Host Interactions
Lamont, R. J., Koo, H., & Hajishengallis, G. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0089-x · Cited by 2,217 · see citing works
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198 · see citing works
<i>Fusobacterium nucleatum</i> infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043 · see citing works
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Franzosa, E. A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H. J., Reinker, S., Vatanen, T., Hall, A. B., Mallick, H., McIver, L. J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0306-4 · Cited by 1,995 · see citing works
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960 · see citing works
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904 · see citing works
Dietary intervention impact on gut microbial gene richness
Cotillard, A., Kennedy, S. P., Kong, L. C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Quinquis, B., Levenez, F., Galleron, N., et al. (2013) · Nature · doi:10.1038/nature12480 · Cited by 1,832 · see citing works
Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011
Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Finkelstein, J. A., Gerber, J. S., Hyun, D. Y., Linder, J. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.4151 · Cited by 1,740 · see citing works
Dominant and diet-responsive groups of bacteria within the human colonic microbiota
Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., Brown, D., Stares, M. D., Scott, P., Bergerat, A., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.118 · Cited by 1,632 · see citing works
Islami, F., Goding Sauer, A., Miller, K. D., Siegel, R. L., Fedewa, S. A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Ma, J., Soerjomataram, I., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21440 · Cited by 1,610 · see citing works
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574 · see citing works
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Sanna, S., van Zuydam, N. R., Mahajan, A., Kurilshikov, A., Vich Vila, A., Võsa, U., Mujagic, Z., Masclee, A. A. M., Jonkers, D. M. A. E., Oosting, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0350-x · Cited by 1,539 · see citing works
Gut microbiome development along the colorectal adenoma-carcinoma sequence
Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., Jie, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms7528 · Cited by 1,506 · see citing works
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
Liu, R., Hong, J., Xu, X., Feng, Q., Zhang, D., Gu, Y., Shi, J., Zhao, S., Liu, W., Wang, X., et al. (2017) · Nature Medicine · doi:10.1038/nm.4358 · Cited by 1,501 · see citing works
Exercise and associated dietary extremes impact on gut microbial diversity
Clarke, S. F., Murphy, E. F., O'Sullivan, O., Lucey, A. J., Humphreys, M., Hogan, A., Hayes, P., O'Reilly, M., Jeffery, I. B., Wood-Martin, R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306541 · Cited by 1,439 · see citing works
Yachida, S., Mizutani, S., Shiroma, H., Shiba, S., Nakajima, T., Sakamoto, T., Watanabe, H., Masuda, K., Nishimoto, Y., Kubo, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0458-7 · Cited by 1,429 · see citing works
Potential of fecal microbiota for early-stage detection of colorectal cancer
Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145645 · Cited by 1,375 · see citing works
Wirbel, J., Pyl, P. T., Kartal, E., Zych, K., Kashani, A., Milanese, A., Fleck, J. S., Voigt, A. Y., Palleja, A., Ponnudurai, R., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0406-6 · Cited by 1,373 · see citing works
A new genomic blueprint of the human gut microbiota
Almeida, A., Mitchell, A. L., Boland, M., Forster, S. C., Gloor, G. B., Tarkowska, A., Lawley, T. D., & Finn, R. D. (2019) · Nature · doi:10.1038/s41586-019-0965-1 · Cited by 1,314 · see citing works
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012) · The ISME Journal · doi:10.1038/ismej.2011.109 · Cited by 1,287 · see citing works
Human colonic microbiota associated with diet, obesity and weight loss
Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P., & Flint, H. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.155 · Cited by 1,222 · see citing works
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205 · see citing works
Duncan, S. H., Louis, P., & Flint, H. J. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.10.5810-5817.2004 · Cited by 1,124 · see citing works
Bingham, S. A., Day, N., Luben, R., Ferrari, P., Slimani, N., Norat, T., Clavel‐Chapelon, F., Kesse‐Guyot, E., Nieters, A., Boeing, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13174-1 · Cited by 1,109 · see citing works
Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., et al. (2018) · Science · doi:10.1126/science.aah3648 · Cited by 1,105 · see citing works
<i>Fusobacterium nucleatum</i> in colorectal carcinoma tissue and patient prognosis
Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310101 · Cited by 1,080 · see citing works
Self-citationDysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063 · see citing works
Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, S., Karcher, N., Pozzi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0405-7 · Cited by 1,030 · see citing works
Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer
Chen, W., Liu, F., Ling, Z., Tong, X., & Xiang, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039743 · Cited by 1,029 · see citing works
Links between diet, gut microbiota composition and gut metabolism
Flint, H. J., Duncan, S. H., Scott, K. P., & Louis, P. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001463 · Cited by 1,020 · see citing works
Yang, Y. P., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.11.018 · Cited by 1,015 · see citing works
Dubin, K., Callahan, M. K., Ren, B., Khanin, R., Viale, A., Ling, L., No, D., Gobourne, A., Littmann, E., Huttenhower, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms10391 · Cited by 987 · see citing works
Fat, fibre and cancer risk in African Americans and rural Africans
O’Keefe, S. J. D., Li, J. V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J. M., Kinross, J., Wahl, E., Ruder, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7342 · Cited by 982 · see citing works
Gut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970 · see citing works
Human Gut Microbiome and Risk for Colorectal Cancer
Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J. J., Hayes, R. B., & Yang, L. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt300 · Cited by 947 · see citing works
A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2819 · Cited by 903 · see citing works
Microbiota: a key orchestrator of cancer therapy
Roy, S., & Trinchieri, G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.13 · Cited by 883 · see citing works
Belenguer, A., Duncan, S. H., Calder, A. G., Holtrop, G., Louis, P., Lobley, G. E., & Flint, H. J. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.5.3593-3599.2006 · Cited by 856 · see citing works
Microbial Dysbiosis in Colorectal Cancer (CRC) Patients
Sobhani, I., Tap, J., Roudot‐Thoraval, F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., Nhieu, J. T. V., & Furet, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016393 · Cited by 832 · see citing works
Greenblum, S., Turnbaugh, P. J., & Borenstein, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116053109 · Cited by 821 · see citing works
Exercise alters gut microbiota composition and function in lean and obese humans
ALLEN, J. M., MAILING, L. J., NIEMIRO, G. M., MOORE, R., COOK, M. D., WHITE, B. A., HOLSCHER, H. D., & WOODS, J. A. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001495 · Cited by 820 · see citing works
Tumour-associated and non-tumour-associated microbiota in colorectal cancer
Flemer, B., Lynch, D. B., Brown, J. M. R., Jeffery, I. B., Ryan, F. J., Claesson, M. J., O'Riordain, M., Shanahan, F., & O'Toole, P. W. (2017) · Gut · doi:10.1136/gutjnl-2015-309595 · Cited by 804 · see citing works
The Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.004 · Cited by 777 · see citing works
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Wang, Y., Wiesnoski, D. H., Helmink, B. A., Gopalakrishnan, V., Choi, K., DuPont, H. L., Jiang, Z.-D., Abu-Sbeih, H., Sanchez, C. A., Chang, C.-C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0238-9 · Cited by 740 · see citing works
Gut mucosal microbiome across stages of colorectal carcinogenesis
Nakatsu, G., Li, X., Zhou, H., Sheng, J., Wong, S. H., Wu, W. K. K., Ng, S. C., Tsoi, H., Dong, Y., Zhang, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9727 · Cited by 701 · see citing works
Microbiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700 · see citing works
Nutrients, foods, and colorectal cancer prevention
Song, M., Garrett, W. S., & Chan, A. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.035 · Cited by 700 · see citing works
Self-citationSo, D., Whelan, K., Rossi, M., Morrison, M., Holtmann, G., Kelly, J. T., Shanahan, E. R., Staudacher, H. M., & Campbell, K. L. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy041 · Cited by 683 · see citing works
<i>Fusobacterium nucleatum</i> and T Cells in Colorectal Carcinoma
Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669 · see citing works
Self-citationAdiposity and cancer risk: new mechanistic insights from epidemiology
Renehan, A. G., Zwahlen, M., & Egger, M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3967 · Cited by 654 · see citing works
The role of the microbiome in cancer development and therapy
Bhatt, A. P., Redinbo, M. R., & Bultman, S. J. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21398 · Cited by 653 · see citing works
Barton, W., Penney, N. C., Cronin, O., Garcia-Perez, I., Molloy, M. G., Holmes, E., Shanahan, F., Cotter, P. D., & O'Sullivan, O. (2018) · Gut · doi:10.1136/gutjnl-2016-313627 · Cited by 647 · see citing works
The oral microbiota in colorectal cancer is distinctive and predictive
Flemer, B., Warren, R. D., Barrett, M. P., Cisek, K., Das, A., Jeffery, I. B., Hurley, E., O‘Riordain, M., Shanahan, F., & O‘Toole, P. W. (2018) · Gut · doi:10.1136/gutjnl-2017-314814 · Cited by 646 · see citing works
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults
Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070803 · Cited by 642 · see citing works
The Human Gut Bacterial Genotoxin Colibactin Alkylates DNA
Wilson, M. R., Jiang, Y., Villalta, P. W., Stornetta, A., Boudreau, P. D., Carrá, A., Brennan, C. A., Chun, E., Ngo, L., Samson, L. D., et al. (2019) · Science · doi:10.1126/science.aar7785 · Cited by 635 · see citing works
Wang, J., Thingholm, L. B., Skiecevičienė, J., Rausch, P., Kummen, M., Hov, J. R., Degenhardt, F., Heinsen, F.-A., Rühlemann, M. C., Szymczak, S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3695 · Cited by 625 · see citing works
Self-citationThe Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625 · see citing works
Gut microbiome composition is linked to whole grain-induced immunological improvements
Martínez, I., Lattimer, J. M., Hubach, K. L., Case, J. A., Yang, J., Weber, C. G., Louk, J. A., Rose, D. J., Kyureghian, G., Peterson, D. A., et al. (2013) · The ISME Journal · doi:10.1038/ismej.2012.104 · Cited by 614 · see citing works
Schiattarella, G. G., Sannino, A., Toscano, E., Giugliano, G., Gargiulo, G., Franzone, A., Trimarco, B., Esposito, G., & Perrino, C. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx342 · Cited by 563 · see citing works
Towards the Human Colorectal Cancer Microbiome
Marchesi, J. R., Dutilh, B. E., Hall, N., Peters, W. H. M., Roelofs, R., Boleij, A., & Tjalsma, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020447 · Cited by 552 · see citing works
The human gut microbiome as a screening tool for colorectal cancer
Zackular, J. P., Rogers, M. A. M., Ruffin, M. T., & Schloss, P. D. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0129 · Cited by 551 · see citing works
Dai, Z., Coker, O. O., Nakatsu, G., Wu, W. K. K., Zhao, L., Chen, Z., Chan, F. K. L., Kristiansen, K., Sung, J. J. Y., Wong, S. H., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0451-2 · Cited by 545 · see citing works
Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544 · see citing works
High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer
Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., & Bonnet, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056964 · Cited by 535 · see citing works
Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women
Liu, P.-H., Wu, K., Ng, K., Zauber, A. G., Nguyen, L. H., Song, M., He, X., Fuchs, C. S., Ogino, S., Willett, W. C., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4280 · Cited by 514 · see citing works
Self-citationEnteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer
Coker, O. O., Nakatsu, G., Dai, R. Z., Wu, W. K. K., Wong, S. H., Ng, S. C., Chan, F. K. L., Sung, J. J. Y., & Yu, J. (2019) · Gut · doi:10.1136/gutjnl-2018-317178 · Cited by 511 · see citing works
Differences in gut microbiota profile between women with active lifestyle and sedentary women
Bressa, C., Bailén-Andrino, M., Pérez-Santiago, J., González-Soltero, R., Pérez, M., Montalvo-Lominchar, M. G., Maté-Muñoz, J. L., Domínguez, R., Moreno, D., & Larrosa, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171352 · Cited by 501 · see citing works
Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., Bruha, J., Neary, P., Dezeeuw, N., Tommasino, M., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2081-3 · Cited by 498 · see citing works
Wang, Z., Bergeron, N., Levison, B. S., Li, X. S., Chiu, S., Jia, X., Koeth, R. A., Li, L., Wu, Y., Tang, W. H. W., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy799 · Cited by 496 · see citing works
Zeng, H., Umar, S., Rust, B., Lazarova, D., & Bordonaro, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051214 · Cited by 480 · see citing works
Donohoe, D. R., Holley, D., Collins, L. B., Montgomery, S. A., Whitmore, A. C., Hillhouse, A., Curry, K. P., Renner, S. W., Greenwalt, A., Ryan, E. P., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0501 · Cited by 479 · see citing works
Estaki, M., Pither, J., Baumeister, P., Little, J. P., Gill, S. K., Ghosh, S., Ahmadi-Vand, Z., Marsden, K. R., & Gibson, D. L. (2016) · Microbiome · doi:10.1186/s40168-016-0189-7 · Cited by 476 · see citing works
Colonization of the Human Gut by <i>E. coli</i> and Colorectal Cancer Risk
Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Déchelotte, P., Bonnet, R., Pezet, D., & Darfeuille-Michaud, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1343 · Cited by 475 · see citing works
THABANE, M., KOTTACHCHI, D. T., & MARSHALL, J. K. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03399.x · Cited by 466 · see citing works
<i>Fusobacterium</i> in Colonic Flora and Molecular Features of Colorectal Carcinoma
Tahara, T., Yamamoto, E., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelinek, J., Yamano, H.-O., Sugai, T., An, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1865 · Cited by 465 · see citing works
A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer
Ulger Toprak, N., Yagci, A., Gulluoglu, B. M., Akin, M. L., Demirkalem, P., Celenk, T., & Soyletir, G. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01494.x · Cited by 454 · see citing works
Microbial butyrate and its role for barrier function in the gastrointestinal tract
Plöger, S., Stumpff, F., Penner, G. B., Schulzke, J., Gäbel, G., Märtens, H., Shen, Z., Günzel, D., & Aschenbach, J. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06553.x · Cited by 445 · see citing works
Microbial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440 · see citing works
Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome
Shoaie, S., Ghaffari, P., Kovatcheva‐Datchary, P., Mardinoğlu, A., Sen, P., Pujos‐Guillot, E., de Wouters, T., Juste, C., Rizkalla, S. W., Chilloux, J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.001 · Cited by 417 · see citing works
Lassenius, M., Pietiläinen, K., Kaartinen, K., Pussinen, P., Syrjänen, J., Forsblom, C., Pörsti, I., Rissanen, A., Kaprio, J., Mustonen, J., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2197 · Cited by 404 · see citing works
Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes
Nakatsu, G., Zhou, H., Wu, W. K. K., Wong, S. H., Coker, O. O., Dai, Z., Li, X., Szeto, C.-H., Sugimura, N., Lam, T. Y.-T., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.018 · Cited by 386 · see citing works
Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing
Vogtmann, E., Hua, X., Zeller, G., Sunagawa, S., Voigt, A. Y., Hercog, R., Goedert, J. J., Shi, J., Bork, P., & Sinha, R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155362 · Cited by 366 · see citing works
Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention
Song, M., & Chan, A. T. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.012 · Cited by 355 · see citing works
Self-citationBaxter, N. T., Ruffin, M. T., Rogers, M. A. M., & Schloss, P. D. (2016) · Genome Medicine · doi:10.1186/s13073-016-0290-3 · Cited by 354 · see citing works
Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis
Wu, S., Zhang, Y., Lu, R., Xia, Y., Zhou, D., Petrof, E. O., Claud, E. C., Chen, D., Chang, E. B., Carmeliet, G., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307436 · Cited by 346 · see citing works
Self-citationNosho, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.557 · Cited by 344 · see citing works
Bile acids as endogenous etiologic agents in gastrointestinal cancer
Bernstein, H., Bernstein, C., Payne, C. M., & Dvorak, K. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.3329 · Cited by 340 · see citing works
Abdulamir, A. S., Hafidh, R. R., & Bakar, F. A. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-11 · Cited by 339 · see citing works
Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer
Liang, Q., Chiu, J., Chen, Y., Huang, Y., Higashimori, A., Fang, J., Brim, H., Ashktorab, H., Ng, S. C., Ng, S. S. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1599 · Cited by 332 · see citing works
Mehta, R. S., Nishihara, R., Cao, Y., Song, M., Mima, K., Qian, Z. R., Nowak, J. A., Kosumi, K., Hamada, T., Masugi, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6374 · Cited by 325 · see citing works
Self-citationVitaglione, P., Mennella, I., Ferracane, R., Rivellese, A. A., Giacco, R., Ercolini, D., Gibbons, S. M., Storia, A. L., Gilbert, J. A., Jonnalagadda, S. S., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.088120 · Cited by 325 · see citing works
Chen, H.-M., Yu, Y.-N., Wang, J.-L., Lin, Y.-W., Kong, X., Yang, C.-Q., Yang, L., Liu, Z.-J., Yuan, Y.-Z., Liu, F., et al. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.046607 · Cited by 321 · see citing works
Wong, S. H., Kwong, T. N. Y., Chow, T.-C., Luk, A. K. C., Dai, R. Z. W., Nakatsu, G., Lam, T. Y. T., Zhang, L., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312766 · Cited by 310 · see citing works
Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer
Cockbain, A. J., Toogood, G. J., & Hull, M. (2011) · Gut · doi:10.1136/gut.2010.233718 · Cited by 305 · see citing works
Association between intraepithelial Escherichia coli and colorectal cancer
Swidsinski, A. V., Khilkin, M., Kerjaschki, D., Schreiber, S., Ortner, M., Weber, J., & Lochs, H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70194-5 · Cited by 302 · see citing works
Diagnostic potential and interactive dynamics of the colorectal cancer virome
Hannigan, G. D., Duhaime, M. B., Ruffin, M. T., Koumpouras, C. C., & Schloss, P. D. (2018) · mBio · doi:10.1128/mbio.02248-18 · Cited by 298 · see citing works
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
Randrianarisoa, E., Lehn-Stefan, A., Wang, X., Hoene, M., Peter, A., Heinzmann, S. S., Zhao, X., Königsrainer, I., Königsrainer, A., Balletshofer, B., et al. (2016) · Scientific Reports · doi:10.1038/srep26745 · Cited by 296 · see citing works
Scott, A. J., Alexander, J. L., Merrifield, C. A., Cunningham, D., Jobin, C., Brown, R., Alverdy, J., O’Keefe, S. J., Gaskins, H. R., Teare, J., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318556 · Cited by 288 · see citing works
Ito, M., Kanno, S., Nosho, K., Sukawa, Y., Mitsuhashi, K., Kurihara, H., Igarashi, H., Takahashi, T., Tachibana, M., Takahashi, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29488 · Cited by 288 · see citing works
Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location
Mima, K., Cao, Y., Chan, A. T., Qian, Z. R., Nowak, J. A., Masugi, Y., Shi, Y., Song, M., da Silva, A., Gu, M., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.53 · Cited by 284 · see citing works
Self-citationVanegas, S. M., Meydani, M., Barnett, J. B., Goldin, B., Kane, A., Rasmussen, H., Brown, C., Vangay, P., Knights, D., Jonnalagadda, S., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.146928 · Cited by 277 · see citing works
Stability of the human faecal microbiome in a cohort of adult men
Mehta, R. S., Abu-Ali, G. S., Drew, D. A., Lloyd-Price, J., Subramanian, A., Lochhead, P., Joshi, A. D., Ivey, K. L., Khalili, H., Brown, G. T., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0096-0 · Cited by 273 · see citing works
Self-citationMurphy, N., Norat, T., Ferrari, P., Jenab, M., Bueno-de-Mesquita, B., Skeie, G., Dahm, C. C., Overvad, K., Olsen, A., Tjønneland, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039361 · Cited by 271 · see citing works
Louis, S., Tappu, R.-M., Damms-Machado, A., Huson, D. H., & Bischoff, S. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149564 · Cited by 269 · see citing works
Diet and nutritional factors in inflammatory bowel diseases
Owczarek, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.895 · Cited by 263 · see citing works
Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet
Candela, M., Biagi, E., Soverini, M., Consolandi, C., Quercia, S., Severgnini, M., Peano, C., Turroni, S., Rampelli, S., Pozzilli, P., et al. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516001045 · Cited by 260 · see citing works
Perspective: Alpha-Bugs, Their Microbial Partners, and the Link to Colon Cancer
Sears, C. L., & Pardoll, D. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/jinfdis/jiq061 · Cited by 259 · see citing works
Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Barrea, L., Annunziata, G., Muscogiuri, G., Somma, C. D., Laudisio, D., Maisto, M., de Alteriis, G., Tenore, G. C., Colao, A., & Savastano, S. (2018) · Nutrients · doi:10.3390/nu10121971 · Cited by 257 · see citing works
Gut microbiota, inflammation and colorectal cancer
Sun, J., & Kato, I. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.03.004 · Cited by 257 · see citing works
Viljoen, K. S., Dakshinamurthy, A., Goldberg, P., & Blackburn, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119462 · Cited by 256 · see citing works
Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans
Scott, T. A., Quintaneiro, L. M., Norvaisas, P., Lui, P. P., Wilson, M. P., Leung, K.-Y., Herrera-Dominguez, L., Sudiwala, S., Pessia, A., Clayton, P. T., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.040 · Cited by 254 · see citing works
Bae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1835 · Cited by 253 · see citing works
Culture‐independent analysis of the gut microbiota in colorectal cancer and polyposis
Scanlan, P. D., Shanahan, F., Clune, Y., Collins, J. K., O'Sullivan, G. C., O'Riordan, M., Holmes, E., Wang, Y., & Marchesi, J. R. (2008) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01503.x · Cited by 245 · see citing works
Bacterial metabolism affects the C. elegans response to cancer chemotherapeutics
García-González, A. P., Ritter, A. D., Shrestha, S., Andersen, E. C., Yilmaz, L. S., & Walhout, A. J. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.046 · Cited by 243 · see citing works
Prorok-Hamon, M., Friswell, M. K., Alswied, A., Roberts, C. L., Song, F., Flanagan, P. K., Knight, P., Codling, C., Marchesi, J. R., Winstanley, C., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304739 · Cited by 236 · see citing works
Increased serum deoxycholic acid levels in men with colorectal adenomas
Bayerdörffer, E., Mannes, G. A., Richter, W. O., Ochsenkühn, T., Wiebecke, B., Köpcke, W., & Paumgartner, G. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90846-5 · Cited by 234 · see citing works
Cronin, O., Barton, W., Skuse, P., Penney, N. C., Garcia-Perez, I., Murphy, E. F., Woods, T., Nugent, H., Fanning, A., Melgar, S., et al. (2018) · mSystems · doi:10.1128/msystems.00044-18 · Cited by 232 · see citing works
Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment
Burns, M. B., Lynch, J., Starr, T. K., Knights, D., & Blekhman, R. (2015) · Genome Medicine · doi:10.1186/s13073-015-0177-8 · Cited by 231 · see citing works
Purcell, R. V., Pearson, J., Aitchison, A., Dixon, L., Frizelle, F. A., & Keenan, J. I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171602 · Cited by 230 · see citing works
Seganfredo, F. B., Blume, C. A., Moehlecke, M., Giongo, A., Casagrande, D. S., Spolidoro, J. V. N., Padoin, A. V., Schaan, B. D., & Mottin, C. C. (2017) · Obesity Reviews · doi:10.1111/obr.12541 · Cited by 228 · see citing works
Colon carcinogens: Their metabolism and mode of action
Weisburger, J. H. (1971) · Cancer · doi:10.1002/1097-0142(197107)28:1 · Cited by 227 · see citing works
Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
Purcell, R. V., Visnovska, M., Biggs, P. J., Schmeier, S., & Frizelle, F. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11237-6 · Cited by 227 · see citing works
Moreno-Navarrete, J. M., Ortega, F., Serino, M., Luche, E., Waget, A., Pardo, G., Salvador, J., Ricart, W., Frühbeck, G., Burcelin, R., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.256 · Cited by 223 · see citing works
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans
Sanapareddy, N., Legge, R. M., Jovov, B., McCoy, A. N., Burcal, L., Araújo-Pérez, F., Randall, T. A., Galanko, J. A., Benson, A. K., Sandler, R. S., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.43 · Cited by 217 · see citing works
Race-dependent association of sulfidogenic bacteria with colorectal cancer
Yazici, C., Wolf, P. G., Kim, H., Cross, T.-W. L., Vermillion, K., Carroll, T., Augustus, G. J., Mutlu, E., Tussing-Humphreys, L., Braunschweig, C., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313321 · Cited by 215 · see citing works
Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes
Shan, Z., Sun, T., Huang, H., Chen, S., Chen, L., Luo, C., Yang, W., Yang, X., Yao, P., Cheng, J., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.157107 · Cited by 210 · see citing works
The gastrointestinal microbiota and colorectal cancer
Keku, T. O., Dulal, S., Deveaux, A. E., Jovov, B., & Han, X. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2012 · Cited by 205 · see citing works
Kunzmann, A. T., Coleman, H. G., Huang, W., Kitahara, C. M., Cantwell, M. M., & Berndt, S. I. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.113282 · Cited by 202 · see citing works
Shifts in the Fecal Microbiota Associated with Adenomatous Polyps
Hale, V. L., Chen, J., Johnson, S. P., Harrington, S. C., Yab, T. C., Smyrk, T. C., Nelson, H., Boardman, L. A., Druliner, B. R., Levin, T. R., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0337 · Cited by 200 · see citing works
Malik, A., Sharma, D., Malireddi, R. K. S., Guy, C. S., Chang, T., Olsen, S. R., Neale, G. A. M., Vogel, P., & Kanneganti, T. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.024 · Cited by 198 · see citing works
Fiber Intake and Survival After Colorectal Cancer Diagnosis
Song, M., Wu, K., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3684 · Cited by 197 · see citing works
Self-citationMucosal adherent bacterial dysbiosis in patients with colorectal adenomas
Lü, Y., Chen, J., Zheng, J.-Y., Hu, G., Wang, J., Huang, C., Lou, L., Wang, X., & Zeng, Y. (2016) · Scientific Reports · doi:10.1038/srep26337 · Cited by 196 · see citing works
Exploring gut microbes in human health and disease: Pushing the envelope
Sun, J., & Chang, E. B. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.08.001 · Cited by 194 · see citing works
Self-citationMetabolite profiling of fecal water extracts from human colorectal cancer
Monleón, D., Morales, J. M., Barrasa, A., López, J. A., Vázquez, C., & Celda, B. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1345 · Cited by 186 · see citing works
Short- and Long-term Effects of Bacterial Gastrointestinal Infections
Ternhag, A., Törner, A., Svensson, Å., Ekdahl, K., & Giesecke, J. (2008) · Emerging infectious diseases · doi:10.3201/eid1401.070524 · Cited by 185 · see citing works
Shah, M. S., DeSantis, T. Z., Weinmaier, T., McMurdie, P. J., Cope, J. L., Altrichter, A., Yamal, J.-M., & Hollister, E. B. (2018) · Gut · doi:10.1136/gutjnl-2016-313189 · Cited by 180 · see citing works
Heianza, Y., Sun, D., Li, X., DiDonato, J. A., Bray, G. A., Sacks, F. M., & Qi, L. (2019) · Gut · doi:10.1136/gutjnl-2018-316155 · Cited by 177 · see citing works
Association of <i>Fusobacterium nucleatum</i> infection with colorectal cancer in Chinese patients
Li, Y.-Y., Ge, Q.-X., Cao, J., Zhou, Y.-J., Du, Y.-L., Shen, B., Wan, Y.-J. Y., & Nie, Y.-Q. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3227 · Cited by 175 · see citing works
Periodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study
Michaud, D. S., Lu, J., Peacock-Villada, A. Y., Barber, J. R., Joshu, C. E., Prizment, A. E., Beck, J. D., Offenbacher, S., & Platz, E. A. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx278 · Cited by 171 · see citing works
Gut microbiota composition correlates with changes in body fat content due to weight loss
Remely, M., Tesar, I., Hippe, B., Gnauer, S., Rust, P., & Haslberger, A. G. (2015) · Beneficial Microbes · doi:10.3920/bm2014.0104 · Cited by 162 · see citing works
The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease
Boleij, A., & Tjalsma, H. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70107-5 · Cited by 158 · see citing works
Dietary Glycemic Load and Risk of Colorectal Cancer in the Women's Health Study
Higginbotham, S., Zhang, Z., Lee, I.-M. M., Cook, N. R., Giovannucci, E. L., Buring, J. E., & Liu, S. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh020 · Cited by 158 · see citing works
Bultman, S. J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2483 · Cited by 157 · see citing works
Salmonellosis and the gastrointestinal tract: More than just peanut butter
Crum-Cianflone, N. F. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0079-7 · Cited by 157 · see citing works
Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease
Jess, T., Simonsen, J., Nielsen, N. M., Jørgensen, K. T., Bager, P., Ethelberg, S., & Frisch, M. (2010) · Gut · doi:10.1136/gut.2010.223396 · Cited by 154 · see citing works
Chung, L., Orberg, E. T., Geis, A. L., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.02.004 · Cited by 153 · see citing works
Plasma Vitamin D Concentration Influences Survival Outcome After a Diagnosis of Colorectal Cancer
Zgaga, L., Τheodoratou, E., Farrington, S. M., Din, F. V. N., Ooi, L. Y., Głodzik, D., Johnston, S. S., Tenesa, A., Campbell, H., & Dunlop, M. G. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.5947 · Cited by 148 · see citing works
Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.
Bayerdörffer, E., Mannes, G. A., Ochsenkühn, T., Dirschedl, P., Wiebecke, B., & Paumgartner, G. (1995) · Gut · doi:10.1136/gut.36.2.268 · Cited by 146 · see citing works
Bernstein, A. M., Song, M., Zhang, X., Pan, A., Wang, M., Fuchs, C. S., Le, N. T., Chan, A. T., Willett, W. C., Ogino, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135959 · Cited by 143 · see citing works
Self-citationPeriodontal disease, tooth loss and colorectal cancer risk: results from the Nurses’ Health Study
Momen-Heravi, F., Babic, A., Tworoger, S. S., Zhang, L., Wu, K., Smith-Warner, S. A., Ogino, S., Chan, A. T., Meyerhardt, J., Giovannucci, E., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30486 · Cited by 137 · see citing works
Self-citationYang, Y., Cai, Q., Shu, X., Steinwandel, M. D., Blot, W. J., Zheng, W., & Long, J. (2019) · International Journal of Cancer · doi:10.1002/ijc.31941 · Cited by 135 · see citing works
The role of microbiota in the development of colorectal cancer
Dai, Z., Zhang, J., Wu, Q., Chen, J., Liu, J., Wang, L., Chen, C., Xu, J., Zhang, H., Shi, C., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32017 · Cited by 133 · see citing works
Increased colon cancer risk after severe Salmonella infection
Mughini-Gras, L., Schaapveld, M., Kramers, J., Mooij, S., Neefjes-Borst, E. A., Pelt, W. V., & Neefjes, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189721 · Cited by 133 · see citing works
Novel insights into microbiome in colitis and colorectal cancer
Yang, Y., & Jobin, C. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000399 · Cited by 129 · see citing works
Lin, Y., Ma, C., Liu, C., Wang, Z., Yang, J., Liu, X., Shen, Z., & Wu, R. (2016) · Oncotarget · doi:10.18632/oncotarget.8762 · Cited by 126 · see citing works
A prospective study of serum metabolites and colorectal cancer risk
Cross, A. J., Moore, S. C., Boca, S. M., Huang, W., Xiong, X., Stolzenberg‐Solomon, R. Z., Sinha, R. R., & Sampson, J. N. (2014) · Cancer · doi:10.1002/cncr.28799 · Cited by 120 · see citing works
Microvessel quantification and its possible relation with liver metastasis in colorectal cancer
Tomisaki, S., Ohno, S., Ichiyoshi, Y., Kuwano, H., Maehara, Y., & Sugimachi, K. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8 · Cited by 118 · see citing works
Is the Association with Fiber from Foods in Colorectal Cancer Confounded by Folate Intake?
Bingham, S. A., Norat, T., Moskal, A., Ferrari, P., Slimani, N., Clavel‐Chapelon, F., Kesse‐Guyot, E., Nieters, A., Boeing, H., Tjønneland, A. M., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0891 · Cited by 117 · see citing works
Deng, X., Li, Z., Li, G., Li, B., Jin, X., & Lyu, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01607 · Cited by 114 · see citing works
Butt, J., Varga, M. G., Blot, W. J., Teras, L., Visvanathan, K., Le Marchand, L., Haiman, C., Chen, Y., Bao, Y., Sesso, H. D., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.09.054 · Cited by 114 · see citing works
Self-citationMarine ω-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis
Song, M., Zhang, X., Meyerhardt, J. A., Giovannucci, E. L., Ogino, S., Fuchs, C. S., & Chan, A. T. (2016) · Gut · doi:10.1136/gutjnl-2016-311990 · Cited by 112 · see citing works
Self-citationDietary choline and betaine and the risk of distal colorectal adenoma in women
Cho, E., Willett, W. C., Colditz, G. A., Fuchs, C. S., Wu, K., Chan, A. T., Zeisel, S. H., & Giovannucci, E. L. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm082 · Cited by 108 · see citing works
Fiber Intake and Incidence of Colorectal Cancer among 76,947 Women and 47,279 Men
Michels, K. B., Fuchs, C. S., Giovannucci, E. L., Colditz, G. A., Hunter, D. J., Stampfer, M. J., & Willett, W. C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0544 · Cited by 105 · see citing works
Recurrent infection progressively disables host protection against intestinal inflammation
Yang, W. H., Heithoff, D. M., Aziz, P. V., Sperandio, M., Nizet, V., Mahan, M. J., & Marth, J. D. (2017) · Science · doi:10.1126/science.aao5610 · Cited by 104 · see citing works
Salmonella protein AvrA activates the STAT3 signaling pathway in colon cancer
Lu, R., Wu, S., Zhang, Y.-G., Xia, Y., Zhou, Z., Kato, I., Dong, H., Bissonnette, M., & Sun, J. (2016) · Neoplasia · doi:10.1016/j.neo.2016.04.001 · Cited by 99 · see citing works
Self-citationGuertin, K. A., Li, X. S., Graubard, B. I., Albanes, D., Weinstein, S. J., Goedert, J. J., Wang, Z., Hazen, S. L., & Sinha, R. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0948 · Cited by 96 · see citing works
Oral microbiome and history of smoking and colorectal cancer
Kato, I., Vasquez, A. A., Moyerbrailean, G. A., Land, S. J., Sun, J., Lin, H., & Ram, J. L. (2016) · Journal of Epidemiological Research · doi:10.5430/jer.v2n2p92 · Cited by 86 · see citing works
Self-citationAssociation between screen-detected gallstone disease and cancer in a cohort study
Shabanzadeh, D. M., Sørensen, L. T., & Jørgensen, T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.013 · Cited by 79 · see citing works
Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality
Hu, Y., Ding, M., Yuan, C., Wu, K., Smith-Warner, S. A., Hu, F. B., Chan, A. T., Meyerhardt, J. A., Ogino, S., Fuchs, C. S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.010 · Cited by 75 · see citing works
Pataky, Z., Genton, L., Spahr, L., Lazarevic, V., Terraz, S., Gaïa, N., Rubbia-Brandt, L., Golay, A., Schrenzel, J., & Pichard, C. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4179-1 · Cited by 75 · see citing works
Lu, R., Bosland, M., Xia, Y., Zhang, Y.-G., Kato, I., & Sun, J. (2017) · Oncotarget · doi:10.18632/oncotarget.19052 · Cited by 75 · see citing works
Vuholm, S., Nielsen, D. S., Iversen, K., Suhr, J., Westermann, P., Krych, Ł., Andersen, J. R., & Kristensen, M. (2017) · Journal of Nutrition · doi:10.3945/jn.117.250647 · Cited by 74 · see citing works
Guercio, B. J., Sato, K., Niedzwiecki, D., Ye, X., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson, A. B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.5062 · Cited by 74 · see citing works
Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas
Kang, M. S., Edmundson, P., Araújo-Pérez, F., McCoy, A. N., Galanko, J. A., & Keku, T. O. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-91 · Cited by 69 · see citing works
Song, M., & Chan, A. T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.038 · Cited by 67 · see citing works
Self-citationAhmed, I., Chandrakesan, P., Tawfik, O. W., Xia, L., Anant, S., & Umar, S. (2012) · Infection and Immunity · doi:10.1128/iai.00236-12 · Cited by 67 · see citing works
Choline and betaine intake and the risk of colorectal cancer in men
Lee, J. E., Giovannucci, E., Fuchs, C. S., Willett, W. C., Zeisel, S. H., & Cho, E. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1295 · Cited by 67 · see citing works
Vaughan-Shaw, P. G., Zgaga, L., Ooi, L. Y., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317922 · Cited by 64 · see citing works
Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans
Simonsen, J., STRID, M. A., Mølbak, K., Krogfelt, K. A., Linneberg, A. R., & Teunis, P. F. M. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807009314 · Cited by 64 · see citing works
He, X., Wu, K., Zhang, X., Nishihara, R., Cao, Y., Fuchs, C. S., Giovannucci, E. L., Ogino, S., Chan, A. T., & Song, M. (2019) · International Journal of Cancer · doi:10.1002/ijc.32382 · Cited by 60 · see citing works
Self-citationNitter, M., Norgård, B., de Vogel, S., Eussen, S. J. P. M., Meyer, K., Ulvik, A., Ueland, P. M., Nygård, O., Vollset, S. E., Bjørge, T., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu185 · Cited by 57 · see citing works
Lin, Y., Ma, C., Bezabeh, T., Wang, Z., Liang, J., Huang, Y., Zhao, J., Liu, X., Ye, W., Tang, W., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32190 · Cited by 57 · see citing works
Sze, M. A., & Schloss, P. D. (2018) · mBio · doi:10.1128/mbio.00630-18 · Cited by 55 · see citing works
Gut microbiome identifies risk for colorectal polyps
Dadkhah, E., Sikaroodi, M., Korman, L. Y., Hardi, R., Baybick, J. H., Hanzel, D. K., Kuehn, G., Kuehn, T., & Gillevet, P. M. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000297 · Cited by 49 · see citing works
Keithlin, J., Sargeant, J. M., Thomas, M. K., & Fazil, A. (2014) · Epidemiology and Infection · doi:10.1017/s0950268814002829 · Cited by 48 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- Martin, 2004, Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer, Gastroenterology, 127, 80, 10.1053/j.gastro.2004.03.054 · DOI
- Roager, 2019, Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial, Gut, 68, 83, 10.1136/gutjnl-2017-314786 · DOI
- Staels, 2009, Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration, Diabetes Care, 32, S237, 10.2337/dc09-S355 · DOI
- Yazici, 2015, Bilophila wadsworthia is more abundant in the colonic microbiome of colorectal cancer cases compared to healthy controls, Gastroenterology, 148
- Yu, 2017, Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer, Gut, 66, 70, 10.1136/gutjnl-2015-309800 · DOI
Cited by
Sorted by citations
Joh, H.-K., Lee, D. H., Hur, J., Nimptsch, K., Chang, Y., Joung, H., Zhang, X., Rezende, L. F. M., Lee, J. E., Ng, K., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.03.028 · Cited by 122 · see citing works
Self-citationAlvandi, E., Wong, W. K. M., Joglekar, M. V., Spring, K. J., & Hardikar, A. A. (2022) · BMC Medicine · doi:10.1186/s12916-022-02529-4 · Cited by 101 · see citing works
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer
Rizzo, G., Bertotti, A., Leto, S. M., & Vetrano, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01970-2 · Cited by 51 · see citing works
Hong, D., Zhang, C., Wu, W., Lu, X., & Zhang, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1133546 · Cited by 38 · see citing works
Sun, J., Song, J., Yang, J., Chen, L., Wang, Z., Duan, M., Yang, S., Hu, C., & Bi, Q. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.789006 · Cited by 29 · see citing works
Self-citationBugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
Araujo, D. V., Watson, G. A., Oliva, M., Heirali, A., Coburn, B., Spreafico, A., & Siu, L. L. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102125 · Cited by 29 · see citing works
Srikham, K., & Thirabunyanon, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112871 · Cited by 24 · see citing works
Inulin impacts tumorigenesis promotion by colibactin-producing Escherichia coli in ApcMin/+ mice
Oliero, M., Hajjar, R., Cuisiniere, T., Fragoso, G., Calvé, A., & Santos, M. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1067505 · Cited by 19 · see citing works
Cai, J.-A., Zhang, Y.-Z., Yu, E.-D., Ding, W.-Q., Jiang, Q.-W., Cai, Q.-C., & Zhong, L. (2023) · Nutrients · doi:10.3390/nu15132940 · Cited by 9 · see citing works
- Authors
- Song, M., Chan, A. T., & Sun, J.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- University of Illinois Chicago (US)
- Corresponding author
- Chan, Andrew T.
- Sun, Jun
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 158
- Issue
- 2
- Pages
- 322-340
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC6957737
- OpenAlex
- W2978077164
- Cited by
- 752
- References
- 217
- Citations by year
- 2026: 66 · 2025: 124 · 2024: 155 · 2023: 140 · 2022: 125 · 2021: 106 · 2020: 32 · 2019: 2 · 2018: 2
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Gastroenterology (acceptedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (NIDDK R01 DK105118, R01DK114126)
- U.S. Department of Defense
- University of Illinois at Chicago
- Cancer Center, University of Illinois at Chicago
- American Cancer Society (K99 CA215314, MRSG-17-220-01 \u2013 NEC)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- colorectal cancer, gut microbiota, diet, environmental factors, obesity, physical activity, dietary fiber, red and processed meat, whole grains, microbiota metabolites, cancer risk, chemoprevention, cancer screening, immune pathways, metabolic pathways
- MeSH terms
- Gastrointestinal Microbiome, Bacteria, Colon, Feeding Behavior, Humans, Intestinal Mucosa, Mass Screening, Risk Factors, Colorectal Neoplasms, Exercise, Incidence, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review